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Inclusion of almonds in an energy restricted diet has been reported to enhance or 
have no effect on weight loss. Their effects specifically on visceral fat stores during 
energy restriction have not been widely examined. Additionally, almond consumption has 
been associated with reduced blood pressure, but whether this is linked to or is 
independent of changes of body composition has not been examined. Moreover, almond 
consumption during energy restriction may be an effective strategy for reversing the 
negative effects of dieting on cognitive performance. The unique nutrient profile of 
almonds also has the potential to influence cognitive function post-prandially. The post-
lunch dip in cognition is a well-established phenomenon of decreased alertness, memory 
and vigilance after lunch consumption and can be affected by lunch composition. 
Almonds which are higher in fat and lower in carbohydrate may be able to reduce this 
post lunch dip in cognition. Consequently, this dissertation had three primary aims. The 
first aim was to evaluate the effects of almond consumption as part of an energy-
restricted diet on weight, visceral and subcutaneous adipose depots and blood pressure 
compared to a nut-free energy restricted diet. The second aim was to evaluate the effects 
xiii 
 
of almond consumption as part of an energy-restricted diet on cognitive function. The 
third aim was to evaluate the acute effects of almond consumption on the post-lunch dip 
in cognitive function. A secondary objective of this dissertation was to develop an 
analytical approach to identify metabolic profiles associated with almond consumption to 
ascertain compliance in long term clinical trials. 
Overweight and obese adults (n=86, age: 31.4±12.9 yr, body mass index: 
30.4±3.9 kg/m2) were randomly assigned to a 12 week energy restricted (500 kcal/d 
deficit) almond-enriched diet (AED) (n=43) or a comparably energy restricted nut-free 
diet (NFD) (n=43). Participants in the AED group were asked to consume dry-roasted, 
lightly salted almonds providing 15% of energy in individualized energy-restricted diets. 
Participants in the NFD group were asked to avoid all nuts during the intervention period. 
The same participants were also randomized to receive either a high fat lunch (A-HFL) 
(>55% energy from fat, almonds contributing 70-75% lunch energy) or a high 
carbohydrate lunch (HCL) (>85% energy from carbohydrates) at the beginning and end 
of the intervention. 
To isolate biomarkers and metabolite changes related to almond consumption, 
representative samples (pools) of erythrocytes from individuals consuming almonds for 
12 weeks (n=31) or no almonds (n=30) as well as unmasticated almond seeds were 
screened by an untargeted and unbiased metabolomics approach, namely flow injection 
mass spectrometry (FIA-MS). Data on full scan mode, specific neutral loss and precursor 
ion scan modes for shotgun lipidomics, and m/z values compatible with nut flavonoids 
from literature were used. The informative m/z values detected in pooled samples were 
combined into single ion monitoring (SIM) and multiple reaction monitoring (MRM) 
xiv 
 
methods intended for individual sample screening. This shotgun metabolomics study 
identified specific ratios and combinations of membrane lipids that were discriminatory 
of almond consumption from the nut-free diet at the end of the 12 week intervention. 
Eight out of the 31 participants (25.8%) in the almond group and 3 out of the 30 (10%) 
participants in the control group were misclassified indicating a possibility of non-
compliance which was supported by self-reported dietary intake data. All subsequent 
analyses of the primary study outcomes were based on an intention-to treat approach and 
a compliers analysis i.e. analysis of participants compliant to the energy-restriction as 
well as their respective intervention groups as determined by the metabolomics study and 
self-reported dietary intake data. 
The findings from this dissertation research demonstrate that consumption of 
almonds during a weight loss regimen resulted in greater proportional reductions of trunk 
and total body fat as well as diastolic blood pressure compared to the nut-free weight loss 
regimen. Both intervention groups lost similar amounts of weight and visceral adipose 
tissue and had similar reductions in systolic blood pressure over time. Hence, almond 
consumption during energy restriction may help to reduce metabolic disease risk in 
overweight and obese individuals. In addition, both intervention groups demonstrated 
similar improvements in memory and attention indices of cognitive function over time. 
Moreover, consumption of a midday meal caused a post-lunch dip leading to a decline in 
cognitive function. The almond-enriched high-fat lunch reduced the post-lunch dip in 





CHAPTER 1. INTRODUCTION 
1.1 Study Rationale 
With obesity recently being recognized as a disease(1) there is a concerted effort 
towards finding nutrition therapies that can treat obesity and its related health disorders. 
Data from epidemiological and clinical studies suggest that consumption of nuts such as 
almonds may be an effective strategy for lowering the incidence of obesity and 
cardiovascular disease(2,3). Despite their high energy content, the inclusion of almonds in 
an energy-restricted diet does not hinder and may augment weight loss(4,5). This may 
occur by several mechanisms, but probably most importantly, improved dietary 
compliance which is likely attributable to greater sensory variety resulting in higher 
palatability of the diet(6); stronger locus of control(8) leading to a sense of empowerment; 
and possibly, through their slow and sustained energy release thus ameliorating 
physiological process that promote hunger and feeding. The satiating effects of almonds 
may prolong inter-meal intervals, promote smaller meal sizes and reduce the desire to eat 
when not hungry and, hence, contribute to purposeful weight loss(7). Additionally, 
according to the U.S. Food and Drug Administration, consumption of 42.5g nuts, such as 
almonds, in conjunction with a diet low in saturated fat and cholesterol, could diminish 
cardiovascular disease risk(9). Almonds contain a range of nutrients such as unsaturated 
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fats, vitamins, minerals, arginine, polyphenols, fiber etc. that could benefit cardiovascular 
health. The primary goal of weight loss is to maximize the reduction of fat mass while 
retaining fat-free mass. Dietary factors can be equally or even more effective than 
exercise in achieving this outcome. Increasing the proportion of protein in an energy-
restricted diet enhances satiety, energy expenditure and greater relative fat mass loss(10). 
In addition, different types of dietary fat may influence substrate oxidation. 
Monounsaturated fats are oxidized preferentially(11,12), and a diet higher in the 
unsaturated:saturated fat ratio may reduce subcutaneous adipose tissue (SAT)(13), but 
more importantly, visceral adipose tissue (VAT) during weight loss(14). The promotion of 
VAT loss is important clinically as this may translate into the greatest reduction in the 
risk for metabolic diseases. Almonds are a good source of protein and monounsaturated 
fats and their effects on visceral fat loss, in conjunction with energy restriction, have not 
been widely examined. 
Additionally, food-derived peptides reduce the risk of cardiovascular disease(15). 
Arginine is among these peptides that help to reduce blood pressure. It is the 
physiological precursor of nitric oxide which is a vasodilator(16). Certain nuts and seeds 
are good plant-based sources of arginine and studies with peanuts (2.8g arginine per 100g 
peanuts, as indicated in the USDA National Nutrient Database) reveals their ingestion for 
12-weeks leads to a significant reduction in diastolic blood pressure(17). Almonds also 
contain high levels of arginine (2.4g arginine per 100g almonds, as indicated in the 
USDA National Nutrient Database) and an augmentation of reduction in blood-pressure 
could be achieved with almond consumption during weight loss. 
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The process of dieting to lose weight is associated with cognitive function 
impairments(18). Impairments of cognition may be a result of food restriction or anxiety 
related to maintaining a weight loss regimen. Negative effects of dieting on cognitive 
performance have been reversed with nut-supplemented diets higher in fat and lower in 
carbohydrate (LCHF)(19). Hence, learning and memory could be enhanced with the 
inclusion of almonds during weight loss. In addition, a decrease of memory and vigilance 
is often reported after lunch, independent of weight loss(20). This post-lunch dip in 
cognitive performance is a well-established phenomenon. It typically occurs in the early 
afternoon hours after lunch consumption and may partly be exacerbated by high 
carbohydrate meals(21). There is very limited evidence on the effects of nut consumption 
on the post-lunch dip in cognitive function. However, the unique nutrient profile of 
almonds, which are lower in carbohydrate and higher in protein and unsaturated fats, may 
lessen the post-lunch dip. 
Assessing compliance to dietary interventions in long-term clinical trials is 
problematic. Although self-reported measures of intake such as 24-hour food recalls and 
food frequency questionnaires are widely used, these are subjective measures of dietary 
intake(22) and only capture a     	
		
  
	   Currently, there are 
no established analytical methods to ascertain compliance to long-term almond 
consumption. Hence, there is a need to develop analytical approaches that can identify 
metabolic profiles associated with almond consumption that are discriminatory of 
individuals consuming almonds and those that do not in long-term clinical trials. 
Nutritional metabolomics is one such tool that can capture the phenotype of dietary 
exposure in biological samples(23) such as erythrocytes and can be used for this purpose.  
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1.2 Study Objectives 
The main objectives of this dissertation are to: 
  Review the literature on effects of nut consumption on body weight, body 
composition, blood pressure and cognitive function, as well as literature 
pertaining to the post-lunch dip in cognitive function. 
  Determine the effects of almond consumption during energy restriction on weight, 
body composition, visceral adipose tissue and blood pressure in overweight and 
obese adults. 
  Determine the effects of almonds on cognitive function and the post lunch dip in 
energy-restricted overweight and obese adults. 
  Develop a method for the assessment of compliance to long-term almond 
consumption using a shotgun metabolomics approach. 
 
1.3 Organization of dissertation 
This dissertation is organized into chapters that contain published manuscripts or 
manuscripts submitted to peer-reviewed journals. The details of the publications are 
provided at the beginning of the chapters. 
Chapter 2 reviews the effects of nut consumption on appetite, dietary 
compensation, energy expenditure, fat oxidation and body weight. The focus in this 
chapter is on how nut consumption can aid weight management due to their strong 
satiating effects, the inefficient absorption of their energy, and possibly by elevating 
energy expenditure and fat oxidation. 
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Chapter 3 reviews literature on the effects of nut consumption on body 
composition, blood pressure, glycemic control, other cardiovascular disease risk factors 
and cognitive function including the post-lunch dip in cognitive function. This chapter 
establishes the foundation for the outcomes of the almond weight loss clinical trial that 
will be discussed in subsequent chapters. 
Chapter 4 investigates changes in weight, body composition, specifically visceral 
fat and resting blood pressure with almond consumption during 12 weeks of energy 
restriction. Changes in secondary outcomes such as anthropometric measures of visceral 
adiposity such as waist circumference and sagittal abdominal diameter, 24-hour 
ambulatory blood pressure, 24-hour free living appetite ratings, and blood glycemic and 
lipid profiles were also assessed.  
Chapter 5 investigates the acute effects of almond consumption on the post-lunch 
dip in cognitive function as well as changes in cognitive function with almond 
consumption during 12 weeks of energy-restriction. The focus in this chapter is on the 
memory and attention domains of cognitive function.  
Chapter 6 describes the development of a shotgun metabolomics method to 
determine compliance to almond consumption in a weight-loss regimen. The focus was 
on 1) screening for prospective biomarkers that were discriminatory of almond 
consumption from the nut-free diet 2) conducting a performance analysis of specific 
combinations and ratios of prospective biomarkers, 3) determining non-compliance to the 
almond and nut-free diets via group misclassifications observed in the ratio performance 




Chapter 7 summarizes the main dissertation findings and presents future 
directions for research. 
 
1.4 Study aims and hypotheses 
Specific aim 1: To evaluate the effects of almond consumption as part of an energy-
restricted diet on weight, body composition, visceral adipose tissue and blood pressure 
compared to a nut-free diet matched on energy restriction (control). 
Hypothesis 1: Inclusion of almonds in an energy-restricted diet will augment the rate of 
weight loss, lead to greater fat mass loss especially in the visceral depot and reduce blood 
pressure compared to the control. 
Specific aim 2: To evaluate the effects of almond consumption as part of an energy-
restricted diet on cognitive function compared to a nut-free diet matched on energy 
restriction (control).  
Hypothesis 2: Inclusion of almonds in an energy-restricted diet will improve the attention 
and memory domains of cognitive function compared to the control. 
Specific aim 3: To determine the post-prandial changes in cognitive function with almond 
consumption at lunch compared to a high-carbohydrate control lunch.  
Hypothesis 3: Inclusion of almonds in a midday meal will ameliorate the post-lunch 
decline in memory and attention compared to a high carbohydrate control meal by 
lowering the percentage of dietary energy from carbohydrates and increasing the 
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Tree nuts and peanuts are good sources of many nutrients and antioxidants, but 
they are also energy dense. The latter often limits intake because of concerns about their 
possible contribution to positive energy balance. However, evidence to date suggests that 
nuts are not associated with predicted weight gain. This is largely due to their high satiety 
value, leading to strong compensatory dietary responses, inefficiency in absorption of the 
energy they contain, a possible increment in resting energy expenditure, and an 
augmentation of fat oxidation. Preliminary evidence suggests that these properties are 




The long-standing pillars of nutrition advice to optimize health are to practice 
balance, moderation, and variety. If followed, no food must be excluded from the diet and 
each food can make some useful contribution, the value of which is determined by the 
health status and needs of the individual. In an era in which positive energy balance has 
dominated health concerns in Western nations and is a growing problem globally, high-
fat, energy-dense foods have often been identified as especially problematic. Nuts are an 
example, and one in which the science does not support this perspective. This review 
focuses on the role of nut consumption on appetite, energy intake, energy metabolism, 
and body weight. Recent studies that report the effects of nuts on various aspects of 
human energy balance are summarized in Table 2-1. 
 
2.3 Nuts in the context of the whole diet 
Nuts contribute to energy and nutrient intake directly and indirectly via multiple 
mechanisms. First, nuts themselves are rich sources of energy, various nutrients (eg, 
tocopherols, magnesium, potassium), and antioxidants (1, 2). Each form of nut has its 
own inherent sensory profile that is more or less appealing to individual consumers and 
so will influence their ingestive decisions. However, the sensory profile of the raw nut is 
commonly modified through processing. Roasting and frying darken the color, increase 
brittleness, and develop new flavor compounds (3 5). Changes in physical properties are 
of particular importance for the acceptability of nuts (6). A wide array of flavor 
compounds (eg, salt, sugar, cinnamon, and capsaicin) is also added directly to the surface 
of nuts to enhance their appeal. Broadly, such modifications increase sensory variety and, 
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by ameliorating monotony effects (7), may facilitate regular nut consumption and intake 
of the nutrients they contain. Sensory properties are among the strongest determinants of 
ingestive decisions (8, 9). 
There are also indirect effects of nut consumption on total energy and nutrient 
intake. The sensory, nutrient, and/or physical properties of nuts alter gut hormone 
secretion (10, 11) and appetitive responses by consumers (12). In addition, nuts are 
frequently incorporated into the matrix of other foods (eg, confections, baked goods, ice 
cream), changing the flavor profile of both and creating a unique new unified sensory 
stimulus (13) that may guide intake of that item or influence the acceptability and 
selection of other items in the broader diet (14, 15). Whether this promotes greater energy 
intake remains to be determined. 
 
2.4 Appetite and energy intake 
With a few exceptions (16, 17), human feeding trials have shown that nut 
ingestion moderates appetite postprandially. Specifically, the inclusion of almonds and 
peanuts suppresses hunger (18, 19) and desire to eat (19) and increases fullness ratings 
after ingestion (17). Daily consumption of peanuts for 4 d also increased fasting satiety 
and fullness levels (20). These are important properties in weight management because a 
postprandial reduction in hunger may prolong meal latency; a decrease in desire to eat 
may prevent eating in the absence of hunger, and higher fasting satiety and fullness levels 
may translate into smaller meal sizes. 
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The satiating effects of nuts depend on 2 important factors. First, the form of nuts 
exerts differential effects on appetitive sensations. Smaller hunger suppression and 
greater hunger rebound (180 min postingestion) were observed when peanuts were 
consumed in the form of butter compared with whole nuts (18). However, whole almonds 
reportedly induce fullness levels comparable to those of almond butter (17). Second, the 
timing of nut consumption can affect appetite. The consumption of almonds together with 
a meal does little to augment the appetite-modulating effects of that meal, whereas 
consuming almonds alone as snacks blunts hunger and desire-to-eat ratings compared 
with individuals who received no nuts (19, 21). Other work noted that the ingestion of 
peanuts or peanut-containing snacks (300 kcal/d) tended to induce greater energy 
compensation when ingested as snacks relative to when they were consumed as part of a 
lunch meal (22). Hence, the form and timing of nut consumption may modulate 
appetitive sensations, with suggestive evidence that satiation/satiety effects may be 
greater for whole nuts consumed as snacks. 
The underlying mechanisms for the appetitive effects of nut consumption are not 
well understood due to a paucity of studies on the issue. However, the available evidence 
indicates that the satiating effects of nuts are not likely to be mediated by delayed gastric 
emptying (23) or the release of selected appetite-regulating gut peptides including 
glucagon-like peptide 1 (GLP-1), glucose-dependent insulinotropic polypeptide (GIP), or 
ghrelin (10, 17, 20). However, the effect of nut consumption on protein YY (PYY) 
secretion is mixed (10, 20). Furthermore, feeding 3 g of pine nut oil (in the form of fatty 
acids or triglycerides) reportedly decreased prospective food-intake ratings and increased 
the secretion of cholecystokinin (CCK) (11). Together, these studies suggest that the 
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satiating effects of nuts may be mediated by CCK and/or PYY secretion and that this 
effect may stem from the dietary protein or fat content of nuts. Their high unsaturated fat 
content has been proposed as the primary driver of satiety (24, 25). This hypothesis was 
based on evidence that unsaturated fat is oxidized more readily than saturated fats (26) 
and so would generate a more rapid and stronger satiety cue. However, several trials have 
directly tested this hypothesis and have not provided experimental support (27 30). 
An expectation of appetite modulation by nuts is that it will translate into reduced 
energy intake from the balance of the diet by evoking a strong compensatory dietary 
response. Compensation data from trials that used almonds (31 33), hazelnuts (34, 35), 
macadamia nuts (36), peanuts (37, 38), pecans (39, 40), pistachios (41, 42), and walnuts 
(43) suggest that values range from 54% to 104% (18, 31, 33, 37). Thus, the majority of 
the energy provided by nuts is offset by spontaneous adjustments in the total diet. Dietary 
compensation may depend on the form of nuts consumed. Peanuts, in the form of peanut 
butter, produced higher dietary compensation than whole peanuts (104% compared with 
151%) (18), despite evoking a weaker satiety effect (44). In summary, nut ingestion 
suppresses hunger and desire to eat and promotes fullness. These sensations may aid 
dietary compensation that offsets much of the energy contributed by nuts. However, 
strong compensation can also occur independently of reported appetitive effects. This 




2.5 Mastication and the efficiency of nutrient absorption 
Although the nutritive value of nuts is well documented, a growing body of 
evidence indicates that the published values may be substantively modified by the nut's 
physical properties (45). In particular, the structure and high fiber content of nuts modify 
the bioaccessibility and bioavailability of the nutrients they contain. To access the 
nutrients in nuts, their parenchymal cell walls must be disrupted. This may occur by 
enzymatic or microbial degradation or mechanical processing in the mouth (chewing) and 
stomach. The fiber nuts provide may bind with food constituents such as fatty acids, 
reducing the efficiency of their absorption (46). Fiber may also alter gastric emptying and 
gastrointestinal transit times and gut hormone secretion, with implications for appetite 
and energy intake (47). In addition, the cell walls may serve as a source of fermentable 
fiber in the colon, affecting energy balance and gut health (48, 49). Because these 
dynamic processes will largely determine the nutritional impact of nut consumption, they 
are attracting increasing research attention (50). 
Nuts require considerable oral processing effort and this may, in part, account for 
the often-noted less-than-predicted effect of their consumption on body weight (31, 35, 
39, 43). The mechanical act of chewing reportedly generates satiation signals through 
cognitive (51), neural (52), endocrine (12, 53), and physical (eg, gastric emptying) (54) 
mechanisms; augments cephalic phase responses linked to appetite (55 58); influences 
digestion efficiency (12, 59 61); modestly increases energy expenditure (62); and elicits 
dietary compensation (63). 
A number of studies have evaluated the efficiency of energy absorption from 
ground and tree nuts through feeding trials. All showed substantive increases in fecal fat 
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loss with nut consumption, although the values ranged widely from  5% to >20% (12, 
61, 6470). One early trial, in which peanut products constituted 95% of daily fat intake, 
reported the percentage of dietary fat excreted was 17.8% for whole peanuts, 7.0% for 
peanut butter, and 4.5% for peanut oil (68). These results documented a food form effect. 
However, there was also an effect of background diet because these fecal fat-loss values 
were observed when participants were consuming 20 g crude fiber daily, but decreased to 
16.8%, 4.2%, and 1.8% for the 3 peanut forms when the background dietary fiber content 
was reduced to 5 g/d. Presumably, there was greater binding of energy-yielding nutrients, 
especially fatty acids, to the fiber in the high-fiber condition, leading to greater fecal 
excretion. The contribution of background diet to treatment effects may account, in part, 
for differences in absorption efficiency across studies. Subsequent work showed elevated 
fecal fat excretion with nut consumption across different types of nuts, including almonds 
(12, 65, 67, 70), pecans (66), pistachios (69), and peanuts (64). In some (67, 70), but not 
all (61, 69), studies, the increment in fecal fat followed a dose-response pattern. In the 
latest studies conducted in the same laboratory under comparable conditions, fecal fat 
losses associated with 42 g almond and pistachio loads/d were comparable at  4.5 g/d 
(61, 69). However, they were higher with almonds ( 9.1 g/d) compared with pistachios 
( 6.7 g/d) at higher nut intakes (84 g/d). This suggests relative consistency across nuts 
for effects at suggested levels of consumption and possibly a nonlinear dose-response 
relation for some types of nuts. 
These trials raise a number of nutritional issues. First, the inefficiency of 
absorption is a double-edged sword. Whereas this may be beneficial with respect to 
moderating energy intake and the possible contribution of nuts to positive energy balance 
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and weight gain, it also likely reduces the absorption efficiency of lipid-soluble nutrients 
and other macronutrients. Fat accounts for  55% of the increment in fecal energy loss 
when nuts are included in the diet (64), so other energy-yielding substances must also be 
affected. Vitamin E extraction is lower in whole compared with finely ground and 
defatted almonds with added almond oil (45). The availability of all nutrients is increased 
with longer gastrointestinal residence time due, in part, to swelling of cell walls and 
leakage of nutrients out of the parenchymal cells (45). Consequently, nut form can be 
used for selective purposes: that is, consumption of whole nuts when moderating energy 
intake is of primary concern; consumption of chopped, sliced, or finely ground nuts or 
butter or oils when maximization of nutrient intake is the priority. The delayed absorption 
of lipid from whole nuts may also moderate postprandial lipemia (71) and glycemia (17). 
Processing of nuts is an additional factor that influences nutrient bioaccessibility (4). 
Roasting of almonds leads to smaller fragments with greater bioaccessibility of cell 
contents when chewing. Mastication studies of peanuts confirm that the physical 
properties of nuts influence their disintegration characteristics (13). They also show that 
the matrix in which peanuts are embedded modifies chewing behavior but without 
modifying the final nut particle size. Simulated gastric processing of peanuts shows 
graded disintegration rates, from the fastest to the slowest in the following order: frying > 
roasting > boiling > raw (5). 
Second, the data on energy bioaccessibility raise questions about the use of 
Atwater conversion factors for nutrient labeling. A goal of labeling based on standardized 
servings is to permit consumers to make informed choices about the energy content of 
different foods to meet their nutritional goals. The structure of nuts may be different 
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enough from other foods to render labels sufficiently inaccurate to warrant another basis 
for determination of their energy contribution to the diet (61, 69, 72). 
Third, with the introduction of flavorings to nuts to enhance their appeal, 
questions have been raised as to whether flavors modify chewing and health outcomes. 
Because flavors are applied to the outer surface of nuts, they exert a strong sensory 
impact (73) and the actual amount added is limited. Consequently, they would not be 
expected to directly influence health risks associated with the flavor principle (eg, 
exacerbation of hypertension by sodium or hyperglycemia by sugar). However, they 
could theoretically alter oral processing and modify nutrient availability from the nuts 
themselves. The limited available data suggest that among the varieties tested (ie, raw, 
roasted unsalted, roasted salted, and honey roasted), no effects of flavor were reported on 
masticatory outcomes including particle size distribution (74, 75). 
Issues of bioaccessibility raise questions about nutrient delivery between types of 
nuts. Almonds and peanuts have markedly different hardness. The initial break forces for 
almonds and peanuts are reported as follows: raw nut (7442 ± 332 compared with 3046 ± 
380 g), honey roasted (5981 ± 172 compared with 1834 ± 232 g), roasted unsalted (5004 
± 209 compared with 1545 ± 337 g), and roasted salted (4940 ± 267 compared with 1195 
± 289 g) (74, 75). These differences in hardness lead to variation across forms and 
between nut types for indexes of oral processing effort such as number of chews, 
chewing rate, and time spent chewing, but the end result is a strikingly similar profile of 
particle sizes (Figure 2-1). No differences related to BMI have been reported, but 
processing effort is stronger in the fasted compared with sated states (74, 75). Thus, to the 
extent that particle size proxies for nutrient availability, the present literature suggests 
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more commonalities across nuts than differences. This coincides with a large body of 
literature showing similar effects of different nuts on cardiovascular disease risk, 
postprandial glycemia, and body weight (15, 76 78). 
 
2.6 Energy expenditure 
A limited number of trials have explored the effects of nut consumption on 
thermogenesis, either postprandially (also known as diet-induced thermogenesis) or on 
resting energy expenditure (REE). The fatty acid composition of nuts has been the target 
of much of this work. In an acute-feeding setting, the consumption of a meal containing 
walnuts (33% of energy from PUFAs) increased diet-induced thermogenesis significantly 
when compared with a dairy-containing meal (32% of energy from saturated fat) (16). An 
isoenergetic meal containing olive oil (31% of energy from MUFAs) yielded comparable 
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attribution of the elevation of energy expenditure and fat oxidation to the higher PUFA 
content of the walnut and the higher MUFA content in the olive oil meals cannot be 
verified. In addition, the inclusion of almonds [60 g (74) or 54.3 g (31)] and peanuts [52.5 
g (37)], both rich sources of unsaturated fats, into meals has not led to elevated 
thermogenesis. The acute postprandial thermogenic effect of nuts is yet to be confirmed. 
Mixed findings on thermogenesis have been reported from short- and longer-term 
(ranging from 4 d to 12 mo) trials of nut consumption. No effects have been documented 
with walnuts (20, 79). One study with almonds reported no effect, whereas another 
observed an increase that accounted for 14% of the energy contributed by the almonds 
(31, 33). Several studies with peanuts have noted an increase in REE. In one trial, there 
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was an 11% increase after 8 wk of peanut consumption (52.5 g/d). When lean and 
overweight adults were supplemented with peanut oil (as 30% of REE) for 8 wk in 
another study, REE was elevated by 5%, but only in overweight individuals (80). 
Collectively, there is some evidence that nut consumption increases thermogenesis, but 
the data are not robust and there is no clear mechanism. One possibility is that the lipid 
from nuts is absorbed over a prolonged period of time, leading to a small but sustained 
source of substrate that fuels thermogenesis and could appear as an increase in REE. 
 
2.7 Adipose tissue and fat metabolism 
It has been proposed that nut consumption elevates fat oxidation and 
preferentially reduces body fat mass, especially in the viscera. These actions are 
attributed to their high unsaturated fat content. If true, their inclusion in the diet could 
help to prevent or mitigate the effects of metabolic syndrome. Animal studies have shown 
that higher PUFA intakes suppress adipocyte differentiation and downregulate adipocyte 
P2 and adipsin genes (81). However, PUFAs did not have an effect on adipose tissue size 
(82). In rodent retroperitoneal (but not subcutaneous) adipose tissues, fatty acid synthase 
(FAS), hormone-sensitive lipase (HSL), phosphoenolpyruvate carboxykinase (PEPCK), 
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mRNA concentrations decrease with higher PUFA intake, suggesting targeting of the 
visceral fat pool (82). There are also indications that fat metabolism is enhanced by 
higher PUFA intake (83). Mitochondrial protein gene expression is upregulated in the 
epididymal fat of mice fed PUFAs (84). The expression of genes that regulate oxidative 
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factor 1 (Nrf1)] are also elevated (84). 
In one acute-feeding study, a high-PUFA diet (33% of energy) enriched with 
walnuts increased fat oxidation in humans (albeit not significantly) (16). In another study, 
fat oxidation was significantly elevated (50% higher compared with a control diet) 
when 3035 g of walnuts were ingested by overweight and obese adults (85). The 
stronger effects noted in this trial may reflect the difference in participant BMI status. 
Blunted fat oxidation has been reported in adults with high body weight (86), but the 
inclusion of walnuts appears to reverse or normalize impaired fat oxidation. Notably, in 
the latter study, the dietary fat concentration and the composition of fat subtypes were 
matched, suggesting that the fat-oxidizing property of walnuts was not limited to their 
PUFA content alone. There are no human studies of fat oxidation with other nuts, which 
limits extrapolation of the walnut findings. Other nuts are richer sources of MUFAs 
compared with the high PUFA content of walnuts, and MUFAs are reported to induce 
comparable or higher fat oxidation rates (87, 88). This suggests that equal or greater 
effects on fat oxidation may be expected with other nuts. 
Several clinical trials have examined whether elevated fat oxidation induced by 
walnuts translates into fat mass loss over time. In one trial (89), the inclusion of walnuts 
in a weight-maintenance diet of type 2 diabetic adults led to a small reduction in body fat, 
although body weight remained stable during the 6-mo study period. Body fat increased 
in individuals who adhered to the control diet (low-PUFA), and the difference between 
the groups approached significance (P = 0.057). The trend persisted when the 
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intervention period was extended to 1 year, where the inclusion of walnuts produced 
greater fat mass loss relative to the control group despite comparable weight in the groups 
(79). Early evidence suggests that the loss of fat mass derived predominantly from the 
subcutaneous and less from the visceral fat pools, although the size of both fat depots 
decreased over time in the walnut group (79). The effects of PUFAs on different body fat 
pools have been studied more intensively with the use of animal models (81, 90 95). This 
work consistently shows that higher PUFA intake reduces visceral fat. However, findings 
in humans, to date, do not replicate these results (79). Indeed, just the opposite has been 
reported, in which PUFAs appeared to preferentially reduce subcutaneous fat. No 
explanation for the inconsistent outcomes between human and rodent studies is apparent. 
Because subcutaneous and visceral fats are part of total body fat, evidence has shown that 
visceral fat loss is primarily determined by total fat mass loss (96). Human studies 
incorporating different nuts into the diet at realistic doses are needed to determine the 
effect of nut consumption on body composition. Findings may yield insights for 
management of body fatness and risk of metabolic syndrome. 
 
2.8 Nut consumption and body weight 
The literature on nut consumption and body weight has been the topic of several 
reviews (76, 97 104). Generally, epidemiologic studies indicate that incorporating nuts 
into diets on a regular basis does not compromise, and may aid, weight maintenance (14, 
105 111). Because energy balance is the ultimate determinant of body weight, not 
surprisingly, controlled feeding studies using almonds, walnuts, pecans, and macadamia 
nuts all indicate that nut consumption does not cause changes in body weight when 
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energy intake is continually adjusted (14, 40, 112 115). More important, when total 
energy intake is less controlled, studies that involve the inclusion of nuts in habitual diets 
of free-living individuals have also shown that nut consumption does not lead to weight 
gain (36, 116 119). However, it must be noted that these were relatively short-term trials 
with limited power to detect small changes in body weight. Although there are reports of 
small, but significant increases in body weight with nut consumption (30, 120 122), the 
preponderance of evidence indicates that under controlled or free-living situations, nut 
consumption does not promote weight gain. 
Several studies assessing the role of nut consumption in weight-maintenance 
programs have noted a decrease in body weight from baseline (32, 36, 40, 79, 113, 114). 
Whether this is due to a greater thermic effect of food or REE effect of the nuts compared 
with the foods they displaced in the diet has not been established. Nevertheless, current 
data indicate that the inclusion of nuts in a weight-maintenance program will not lead to 
weight gain and may aid weight loss. 
The inclusion of nuts in energy-restriction regimens does not impede weight loss 
(115, 123 126). In several trials in which nuts did not augment weight loss (125, 126), 
there was a reduction in cardiovascular disease risk indexes in the nut-consuming groups, 
suggesting that such benefits derive from properties of the nuts rather than just weight 
change. There is a need for long-term randomized intervention studies with body weight 
as a primary outcome to establish the effect of nuts consumed daily in realistic quantities 





It is now well established that body weight and fatness are functions of energy 
balance rather than the macronutrient content of the diet (125, 127, 128). Nuts are a high-
fat, energy-dense food, but the evidence indicates that they pose little challenge to and 
may even aid weight management. This is attributable to the strong dietary compensation 
effects they elicit, inefficiency in the absorption of the energy they provide, and possibly 
an elevation of energy expenditure and fat oxidation. Although energy is the determinant 
of body weight and composition, the greater health effects of diets will be determined by 
their macronutrient content and other constituents. Nuts are rich sources of unsaturated 
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Table 2-1: A summary of recent trials on human energy balance using a variety of nuts 
Type of nut and 






oxidation Weight Body fat 






and 24 h 24 
500 kcal almonds vs no load 
condition and preloads matched 
on weight and volume      57%         
 Fraser (31) 2002 
Randomized, 
crossover 6 mo 81 320 kcal almonds/d vs no almonds      5478%      
 Jenkins (32) 2002 
Randomized, 
crossover 4 wk 27 
22.2%E from almonds or 11.1%E 
from almonds + 11.1%E from 
muffins vs 22.2%E from muffins               
 Wien (115) 2003 
RCT weight 
loss 24 wk 65 
84 g almonds/d vs isocaloric 
complex carbs               
 Hollis (33) 2007 
Randomized, 
crossover 10 wk 20 344 kcal almonds/d vs no almonds      74%      
 Mori (17) 2011 
Randomized, 
crossover 490 min 14 
43 g almonds vs no almonds, 
almond flour, and almond oil 
groups, all matched on 75 g 
available carbohydrate in 
breakfast meals   

Fullness             
 Novotny (61) 2012 
Randomized, 
crossover 18 d 18 
42 and 84 g almonds/d vs no 






           
 Foster (125) 2012 
RCT weight 
loss 18 mo 123 56 g/d vs no almonds                
 Tan (19,21) 2012 RCT (suppl) 4 wk 137 43 g/d vs no almonds             
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Type of nut and 






oxidation Weight Body fat 




crossover 4 wk 15 
40 g hazelnuts/d vs low-fat diet 
(no hazelnuts)          
 Yücesan (35) 2010 
Prospective 
(suppl) 4 wk 21 1 g hazelnuts/kg per day          
Macadamia 
nuts              
 Garg (36) 2003 
Prospective 
(suppl) 4 wk 17 
4090 g/d (15%E from 
macadamia nuts)         






and 24 h 24 
500 kcal peanuts and PB vs no 
load condition and preloads 
matched on weight and volume    
Peanuts: 104%; 
PB: 151%     
 Alper (37) 2002 Crossover 30 wk 15 
500 kcal peanuts/d: FF vs ADD 




 Griel (14) 2004 Epidemiology NS 14,262 Users vs nonusers       
Negative 
assoc  
 Traoret (64) 2008 
Randomized, 
crossover 79 d 16 70 g peanuts/d vs no peanuts          
 Devitt (22) 2011 
Randomized, 
crossover 300 min 66 300 kcal peanuts vs isocaloric load      	
 

     
Pecans              
 Morgan (39) 2000 
Prospective 
(suppl) 8 wk 19 68 g pecans/d          
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oxidation Weight Body fat 
 Rajaram (40) 2001 
Randomized, 
crossover 4 wk 23 
20%E from pecans vs no pecans, 
both treatments as part of Step 1 
diet           
Pistachios              
 Kocyigit (41) 2006 
Prospective 
(suppl) 3 wk 44 20%E from pistachios          
 Sheridan (42) 2007 
Randomized, 
crossover 4 wk 15 
15%E from pistachios vs no 
pistachios           
 Li (123) 2010 
RCT weight 
loss 12 wk 59 
53 g pistachios/d vs 56 g 
pretzels/d         
 Baer (69) 2012 
Randomized, 
crossover 3 wk 18 
42 and 84 g pistachios/d vs no 




g)      
 Almario (43) 2001 Crossover 6 wk 18 48 g walnuts/d vs no walnuts          
 Tapsell (89) 2004 
RCT weight 
maintenance 6 mo 58 30 g walnuts/d vs no walnuts           	 
 Sabaté (120) 2005 
Randomized, 
crossover 6 mo 90 
2856 g/d (12%E from walnuts) 
vs no walnuts         
Walnuts              
 Casas-
Augustench (16) 2009 
Randomized, 
crossover 5 h 29 
33%E PUFAs from walnut-
enriched meal vs olive oil 
(MUFAs) and dairy product 
(saturated fat)enriched isocaloric 
meals        	   
 Tapsell (85) 2009 
Randomized, 
crossover 8 h 16 
30 g walnut-enriched meal vs 
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oxidation Weight Body fat 
 Tapsell (79) 2009 
RCT weight 
maintenance 12 mo 50 
30 g walnuts/d vs lower-fat diet 
(no walnuts)             
 Brennan (20) 2010 
Randomized, 
crossover 4 d 20 
48 g walnuts/d vs isocaloric 
placebo          
Pine nuts              
 Pasman (11) 2008 
Randomized, 
crossover 240 min 18 
3 g pine nut FFA or 3 g TGs vs 3 
g placebo (olive oil), all in 
combination with breakfast          
Nut not 
specified              
 Ellsworth 





women Eating frequency per week       
Negative 
assoc (NS)  





men Eating frequency per week       No assoc  
 Bes-
Rastrollo (107) 2007 Epidemiology 
Median 




(111) 2011 Epidemiology NS 120,877 Serving size       
Negative 
assoc  
ADD, added to diet; assoc, association; EE, energy expenditure; EI, energy intake; FF, free feeding; FFA, free fatty acids; PB, peanut butter; 
RCT, randomized controlled trial; ref, reference; SUB, replaced equal amount of fat in diet; suppl, supplement; TG, triglyceride; 
,significantly higher; 	, significantly lower, 




Figure 2-1: Particle sizes (in mm) of raw, salted, roasted, and honey roasted almonds and 
peanuts after mastication.  








CHAPTER 3. A LITERATURE REVIEW ON THE EFFECTS OF NUT 
CONSUMPTION ON BODY COMPOSITION, CARDIOVASCULAR HEALTH 
AND COGNITIVE FUNCTION 
3.1 Introduction 
Nuts are high in vegetable protein, fiber, monounsaturated fats (MUFAs), 
polyunsaturated fats (PUFAs), polyphenols, phytosterols and many vitamins and 
minerals(1); nutrients that have beneficial effects on cardiovascular health and cognitive 
function. This chapter explores the literature on the effects of nut intake on other 
outcomes of the dissertation research such as body composition, specifically visceral fat, 
vascular health, lipid profile, glycemic control and cognitive function(1,2). The potential 
role of nut consumption in ameliorating the post-lunch decline in cognitive function is 
also discussed. 
 
3.2 Nut consumption and body composition 
Epidemiological evidence indicates that nut consumption is associated with better 
adiposity measures(3). Moreover, a recent meta-analysis of controlled interventional trials 
found that nut intake does not increase adiposity and, in fact, had an inverse effect on 
adiposity for interventions that imposed energy restriction compared to those focusing on 
weight maintenance(4). This meta-analysis included trials that assessed adiposity using 
anthropometric measures such as BMI and waist circumference. Very few trials have 
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used direct measures to assess changes in adiposity after nut consumption and have 
reported conflicting results. While one weight-loss intervention noted that almond 
consumption for 24 weeks was associated with greater reductions in fat mass when 
assessed using bioelectrical impedance(5), another weight-loss trial of the same duration 
observed reductions in DEXA-assessed fat mass with almond consumption which were 
similar to that of the control(6). Moreover, the Multi-Ethnic Study of Atherosclerosis 
(MESA) demonstrated that nut consumption was associated with decreased adiposity (as 
assessed by computed tomography (CT)) but only in the pericardial area and not in the 
subcutaneous and visceral depots(7).  
Visceral obesity is correlated with various cardio-metabolic disorders and obesity-
related complications. However, very few trials have examined the differential effects of 
nut consumption on subcutaneous and visceral fat loss. Two nut-based interventional 
trials have examined VAT directly and reported conflicting findings(8,9). While one trial 
in diabetic individuals observed that walnut consumption led to significant reductions in 
fat in both visceral and subcutaneous depots(8), the other trial in individuals with 
metabolic syndrome found no reduction in visceral or subcutaneous adipose tissue 
(assessed by MRI) with pistachio consumption for 24 weeks(9). Other studies have 
assessed overall abdominal obesity, but not VAT specifically. For example, in a 6- week 
crossover trial, almond consumption resulted in greater reductions in abdominal fat in 
individuals with elevated LDL-C compared to a control diet(10). Hence, there are very few 
nut-based trials assessing VAT using direct measures such as DEXA, MRI or CT scans 




3.3 Nut consumption and vascular health 
Dietary patterns that incorporate nuts such as the Mediterranean diet, DASH diet 
and the Nordic diet are associated with decreased blood pressure(11). Nuts are high in L-
arginine (2-3g arginine/100g), a precursor for nitric oxide which increases endothelial-
dependent dilation. Nuts are also rich in K and Mg which could assist in reduction of 
blood pressure. However, findings from nut-based clinical trials are somewhat mixed. 
While one meta-analysis investigating cardiovascular outcomes after tree nut 
consumption suggests no effect of tree nuts on resting blood pressure in individuals 
without prevalent CVD(12), another meta-analysis published in the same year found that 
nut consumption led to reductions in systolic blood pressure but only in non-diabetic 
individuals(13). The heterogeneity in the study inclusion criteria and analyses between the 
two meta-analyses could have led to the discrepant findings. The tree nut meta-analysis 
excluded peanuts from the analysis and standardized the effect size to 1 oz. of nuts per 
day(12). In contrast, the other meta-analysis included all tree nuts, peanuts and soy nuts in 
the analysis and did not standardize the nut dose response(13). Nevertheless, the 
preponderance of clinical evidence shows the greatest effects of nuts on blood pressure in 
individuals with some CVD risk factor. For example, peanut consumption for 12 weeks 
was associated with reduction in diastolic blood pressure in individuals at high CVD 
risk(14). Moreover, in the PREDIMED trial, consumption of a nut-based Mediterranean 
diet for one year led to a decrease in 24-hour ambulatory systolic and diastolic BP but 
only in high CVD risk individuals(15). Although there is some data to suggest that almond 
consumption in the context of energy restriction may augment reductions in blood 
pressure(5,16) it is not well characterized.  
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Nut consumption may also have beneficial effects on other indices of vascular 
health such as endothelial function and arterial compliance. A literature review indicates 
that nut consumption results in a 19.7% relative increase in vasodilation when computed 
as weighted average change across 9 studies(2). Although there are benefits, particularly 
with walnut consumption, conclusions for other types of nuts cannot be quantified. There 
is limited evidence regarding the effects of nut consumption on arterial compliance. 
While 40g of pistachio consumption for 3 months led to reduced arterial stiffness(17), 15g 
of walnut consumption for 4 weeks did not(18) suggesting perhaps a dose-dependent 
and/or long-term response. Walnuts are the most extensively researched nuts and are high 
in ALA which is associated with improved endothelial function and neuro-protective 
effects in animal models(2). Almonds and pistachios are high in MUFAs which also 
reduce arterial stiffness(19) and endothelial dysfunction(20). In general, the cholesterol 
lowering effects of nuts can reverse endothelial dysfunction as hypercholesterolemia 
impairs endothelial function(21). This may have important implications for cognitive 
function as discussed later. 
 
3.4 Nut consumption, lipids and inflammation 
Nut consumption promotes cholesterol-reduction(22) and reduces cardiovascular 
risk factors, inflammation and oxidative stress(23). The preponderance of nut-based 
evidence shows the greatest improvements in blood cholesterol in individuals with high 
LDL cholesterol and those with low BMI.  Improvements in triglycerides are greatest in 
individuals with hypertriglyceridemia(22). The cholesterol lowering effects of nut 
consumption appear to be dose-dependent with consumption of 60g of nuts or more per 
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day having the greatest effects(12). Nut consumption is also associated with reductions in 
inflammatory markers such as CRP, IL-6, ICAM-1, VCAM-1, E-selectin and interleukins 
(2). These effects too appear to be dose dependent with doses greater than 30g per day 
having beneficial effects(2). In addition, when nuts replace olive oil in Mediterranean 
diets, improvements in some inflammatory markers are demonstrated(24 26) suggesting 
that nuts have beneficial effects over and above that of the traditional olive oil 
Mediterranean diet.  
 
3.5 Nut consumption and glycemic control 
Several epidemiological studies have demonstrated a protective effect of nut 
consumption on diabetes risk(27,28). Evidence from these studies has led many researchers 
to conduct trials investigating the effects of nut consumption on glycemic control. The 
regulation of glycemia is a critical factor in reducing the risk of diabetes. Nut 
consumption improves postprandial glycemic control in a dose-dependent manner(29 32). 
In addition, nut consumption has second-meal effects on glycemic control(33,34). The 
second meal effect is a phenomenon where a prior meal attenuates postprandial blood 
glucose responses to a subsequent meal(35,36). The form of nuts may determine the 
accessibility of lipids leading to differential effects on glycemic control(33,34,37). For 
example, lipids in more processed forms of almonds such as almond meal and almond 
butter are more accessible for absorption than lipids in whole almonds(38,39). Hence, 
altering the physical form of nuts may have metabolic effects that warrant further study.  
Although the findings from studies examining the chronic effects of nut 
consumption are inconclusive, evidence indicates that nut consumption for 12 weeks or 
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longer has beneficial effects on glycemic control through improvements in insulin 
sensitivity and/or beta-cell function(40,41) and HbA1c concentrations(24,42,43). In contrast, 
short-term studies(44 47) suggest that the consumption of nuts for periods less than 12 
weeks may not be effective in enhancing overall glycemic control or measures of insulin 
sensitivity. Although nut consumption when eaten alone or as a part of meals, has 
positive effects on glycemic control(1), the long term effects are typically more favorable 
in prediabetic(41), and diabetic individuals(42) or those with metabolic syndrome(40). 
 
3.6 Nut consumption and cognitive function 
Epidemiological evidence indicates beneficial effects of nut consumption on 
cognitive function, but mostly in middle aged and older adults. A five year prospective 
cohort study found a positive association between nut consumption and cognitive 
performance(48). The difference in cognitive performance between the lowest and highest 
consumers of nuts was equivalent to a 5 to 8 year age difference(48). In addition, they 
found no cognitive decline in the highest nut consumers over 5 years (amount of nuts 
unspecified). In the PREDIMED study, walnut (but not other nuts) consumption was 
associated with increased working memory in adults aged 55-80 years(49). In another 
cross-sectional study, nut consumption was associated with increased executive function 
and semantic memory in older adults, although the association was non-significant(50). A 
   	
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higher long-term nut intake was associated with better cognitive outcomes(51). In addition, 
women who consumed more than 5 servings of nuts per week had higher scores than 
non-consumers; the difference in scores was equivalent to the difference found in women 
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2 years apart in age. The only interventional trial conducted exclusively in young adults 
observed an 11% increase in inferential verbal reasoning after consumption of 60g 
walnuts/day for 8 weeks(52). They observed no changes in non-verbal reasoning and 
memory scores. Another trial observed improvements in working memory and speed of 
processing with nut-supplemented diets in the context of energy-restriction(53). The 
effects of almond consumption on the memory and attention domains of cognitive 
function in energy-restricted adults has not been explored before. 
The beneficial effects of nuts on cognitive performance are likely due to the 
improvements in cardiovascular risk factors such as lipid profile, arterial compliance, 
glucoregulation, oxidative stress, blood pressure and inflammation, with subsequent 
improvements in endothelial function and cerebral vascular function(2). Improved 
endothelial function is important for regulating cerebral blood flow to deliver nutrient-
rich blood to the brain. Researchers have hypothesized that cognitive performance can be 
improved by improving cerebral blood flow(54,55). 
  
3.7 Potential role of nut consumption on the post-lunch dip in cognitive function 
Although there are circadian variations in cognitive performance during the day 
time, there is an acute decrease in cognitive performance around midday, particularly 
after lunch(56). This post-lunch dip in cognitive performance is a well-established 
phenomenon of decreased cognitive function in the early afternoon hours typically after 
lunch consumption. It is thought to begin approximately one hour after the start of lunch 
consumption(57). During the post-lunch dip, memory and vigilance are the most severely 
affected domains, and decreased mood, alertness and anxiety are also reported(58,59). 
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These symptoms may negatively affect performance and  increase personal and societal 
risks(57,60,61). A dip in cognitive function after lunch may be caused by an increase in 
cortisol levels(62), insulin surges(63) and increased serotonin levels(64). Although there are 
no studies investigating the effects of nut consumption on the post-lunch dip, nuts can 
potentially affect cognitive function post-prandially by manipulating the macronutrient 
composition of the meal. Lunch composition is reported to play a role in the post-lunch 
dip with high-fat lunches leading to slower(65,66) but more accurate(66) responses than low-
fat lunches. High-carbohydrate meals are shown to have a sedative effect promoting 
drowsiness in females and calmness in males(64). Moreover, high carbohydrate and low 
protein meals could increase brain serotonin levels that could affect cognitive function(64). 
The unique nutrient composition of nuts such as almonds which are higher in fat and 
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Background: Inclusion of almonds in an energy restricted diet has been reported to 
enhance or have no effect on weight loss. Their effects specifically on visceral body fat 
stores (VAT) during energy restriction have not been widely examined. Additionally, 
almond consumption has been associated with reduced blood pressure (BP), but whether 
this is linked to or independent of changes of body composition has not been examined.  
Objective: To evaluate the effects of consuming almonds as part of an energy-restricted 
diet on body composition, specifically visceral adipose tissue and blood pressure 
compared to a nut-free energy restricted diet.  
Methods: Eighty-six healthy adults (BMI: 25-40 kg/m2) were randomly assigned to a 12 
week energy restricted (500 kcal/d deficit) almond-enriched diet (AED) or a comparably 
energy restricted nut-free diet (NFD). Participants in the AED group consumed almonds 
providing 15% of energy in their individualized energy-restricted diet. Participants in the 
NFD group avoided nuts during the energy restriction period. This study is registered on 
ClinicalTrials.gov (registration number: NCT02360787) 
Results: Body weight, trunk fat percent, total fat percent, VAT and systolic BP decreased 
after 12 weeks of energy restriction (P<0.05). Compliant participants in the AED group 
had a greater reduction in trunk and total fat percentages (P<0.05), diastolic BP (P<0.05) 
and a greater trend for VAT loss over time compared to those in the NFD group (P<0.05).  
Conclusions: Inclusion of almonds in a weight loss regimen resulted in greater 
proportional reductions of trunk and total body fat as well as diastolic blood pressure 
compared to a nut-free weight loss regimen. Hence, moderate almond consumption 
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4.3 Introduction 
Despite their high energy content, the inclusion of almonds in an energy-restricted 
diet does not compromise and may enhance weight loss (1 3). This may occur by several 
mechanisms, but probably most importantly through improved dietary compliance. This 
is likely attributable to greater sensory variety resulting in higher palatability of the diet 
(4); stronger locus of control (5) leading to a sense of empowerment; and management of 
appetitive sensations through their slow and sustained energy release (6).The satiating 
effects of almonds may prolong inter-meal intervals, promote smaller meal sizes and 
reduce the desire to eat when not hungry and, hence, contribute to purposeful weight loss 
(7). 
A goal of weight loss is to maximize the reduction of fat mass while retaining fat-
free mass. Traditionally, exercise was viewed as the primary way to achieve this 
outcome, but evidence shows that dietary factors can be equally or more effective. 
Increasing the proportion of protein in an energy-restricted diet enhances satiety, energy 
expenditure and greater relative fat mass loss (8). In addition, different types of dietary 
fat may influence substrate oxidization. Monounsaturated fats are oxidized preferentially 
(9,10), and a diet higher in the unsaturated: saturated fat ratio may reduce subcutaneous 
adipose tissue (SAT) (11), but more importantly, visceral adipose tissue (VAT) during 





composition on abdominal fat changes (13). VAT undergoes rapid lipolytic activity 
leading to increased liver fatty acid production. As a consequence, muscle insulin 
sensitivity reduces and insulin secretion is stimulated. Elevated peripheral insulinemia 
will suppress lipolysis and promote lipogenesis, resulting in the accumulation of more 
abdominal and visceral fat (14). The preferential loss of VAT is believed to minimize 
metabolic syndrome and hence improve metabolic fitness. Almonds are good sources of 
protein and monounsaturated fats and their effects on visceral body fat loss, in 
conjunction with energy restriction, have not been widely examined.  
Being overweight increases the risk of hypertension by 46% to 75% (15).  There 
is evidence implicating visceral adiposity as the primary cause of obesity-related 
hypertension (16). Losing weight may reduce blood pressure and this may be augmented 
by incorporating almonds into the diet. Additionally, food-derived peptides such as 
arginine reduce the risk of cardiovascular disease (17). Arginine is the physiological 
precursor of nitric oxide; a vasodilator (18). Nitric oxide inactivation increases blood 
pressure (19). Certain nuts and seeds are good plant-based sources of arginine and studies 
with peanuts (2.8g arginine per 100g peanuts, as indicated in the USDA National 
Nutrient Database) reveals their ingestion for 12 weeks leads to significant reductions in 
diastolic blood pressure (20). Almonds also contain a high level of arginine (2.4g 
arginine per 100g almonds), but their effect on blood pressure is not well characterized. 
The purpose of this study was to evaluate the effects of almond consumption as 
part of an energy-restricted diet on weight, body composition, visceral adipose tissue and 
blood pressure compared to a nut-free diet matched on the level of energy restriction. We 





of weight loss, lead to greater fat loss especially in the visceral depot and reduce blood 




Eighty-six (21 men and 65 women) healthy adults (18 60 y/o) with overweight 
and obesity (BMI: 25-40 kg/m2) were recruited. Eligibility criteria included the 
following: no nut allergies, willingness to consume almonds, not taking medications 
known to influence metabolism and appetite, non-smoker >1 year, consistent diet and 
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registered on ClinicalTrials.gov (registration number: NCT02360787).  All procedures 
involving human subjects were approved by the Purdue Institutional Review Board. 
Participants were recruited via public advertisements. After expressing interest, potential 
participants were asked to complete health and personality questionnaires. Participants 
were excluded from the trial if they had diabetes or pre-diabetes, uncontrolled 
hypertension, cardiovascular disease or dyslipidemia requiring drug therapy. Informed 
consent was obtained from participants who met eligibility criteria prior to 
commencement of study visits. All participants were compensated for their time and 
effort.  
 
4.4.2 Study protocol 
The study was a 12-week randomized, controlled, parallel-arm clinical trial. 





enriched diet (AED) or nut-free diet (NFD). Both groups received dietary counseling 
using the MyPlate food guidance system (21) to reduce energy intake to achieve 500 
kcal/day deficit to support weight loss. Their estimated energy requirement was 
calculated using the Schofield equations (22) with a physical activity level factor of 1.3. 
Participants met with a dietitian on a weekly basis for the first 4 weeks to establish their 
dietary prescription, and every 2 weeks after that to monitor dietary adherence. Weekly 
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maintain their usual physical activity habits throughout the study duration. Compliance to 
physical activity was tracked every 4 weeks on 2 days: one weekday and one weekend 
day, using a previously validated  triaxial accelerometer (RT3, Stayhealthy Inc., USA) 
(23). 
Forty-three participants were randomized into the AED and NFD groups each. 
They were asked to consume dry-roasted, lightly salted almonds providing 15% energy in 
their individualized energy-restricted diet. Energy from almonds was accounted for 
during dietary modeling so that a 500 kcal/day deficit was achieved. Participants in the 
AED group were asked to avoid consumption of other nuts and seeds. Participants in the 
NFD group were asked to avoid all nuts, seeds and nut products during the intervention 
period.  
 
4.4.3 Study outcomes 
The primary outcomes for this study were weight, body composition, visceral 





sagittal abdominal diameter, serum lipids, insulin, glucose, 24-hour ambulatory blood 
pressure and 24-hour free-living appetite. All outcomes were assessed at baseline and 12 
weeks after the intervention. 
 
Anthropometric outcomes 
Body weight was measured using a calibrated scale (Model ABC, Tanita Inc., 
USA) with participants wearing minimal light-weight clothing. Height was measured 
using a wall-mounted stadiometer. Body composition was assessed using dual-energy X-
ray absorptiometry (Lunar iDXA, GE Healthcare, UK). Sagittal abdominal diameter 
(SAD) was measured using a portable sliding caliper (Holtain-Kahn Abdominal Caliper, 
Holtain Limited, UK) placed at the level of the iliac-crest while participants were in a 
supine position. Waist circumference was measured using a measuring tape placed at the 
narrowest part of the torso.  
VAT was predicted using two multivariate anthropometric models. The first 
model was based on proximal thigh circumference, waist circumference, age and/or BMI 
(24) i.e. women: VAT = 2.15 (waist circumference, cm) - 3.63 (proximal thigh 
circumference, cm) + 1.46 (age, y) + 6.22 (BMI, kg/m2) - 92.713; men: VAT = 6 (waist 
circumference, cm)   4.41 (proximal thigh circumference, cm) + 1.19 (age, y)   
213.65(24) (model 1). Proximal thigh height was measured using a measuring tape placed 
around the thigh just distal to the gluteal crease. The second model was based on sagittal 
diameter, age, waist circumference and trunk fat %  i.e. VAT = -208.2 + 4.62 (sagittal 





(model 2). Although this model has only been validated for women, we applied it for men 
as well and examined the correlations between the 2 models with regard to sex. 
 Resting blood pressure was assessed using an automated digital blood pressure 
monitor (Model 6013, American Diagnostic Corporation, USA). The participants rested 
for 5 min prior to blood pressure measurement. Three readings were taken and the 
average was used to determine resting blood pressure. Twenty-four hour ambulatory 
blood pressure in a free-living environment was assessed using an automated ambulatory 
blood pressure machine (ABPM50, Contec, China) that was programmed to measure 
blood pressure every hour from 8 am to 12 am then every 4 hours till 8 am the next day. 
This device was worn on the arm for 24-hours and the cuff periodically inflated and 
deflated to measure blood pressure.  
 
Serum lipids, insulin and glucose  
Fasting blood samples (8ml) obtained from participants were analyzed for serum 
lipids (total, LDL and HDL cholesterol and triglycerides), insulin and glucose using an 
automated sample analyzer COBAS (COBAS integra 400 plus, Roche Diagnostics 
Limited, USA).  
 
24-hour free living appetite ratings 
Hunger, fullness, desire to eat and prospective consumption ratings were 
measured on 100-mm visual analog scales on     	
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4.4.4 Almond acceptance and palatability 
Participants randomized to the AED group rated the acceptability of almonds 
using a food action rating scale (26) and the palatability of almonds using a hedonic 
general labelled magnitude scale (gLMS) (27,28) one week after the start of the 
intervention and at the end of the intervention. 
 
4.4.5 Compliance assessment 
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via self-reported intake (24-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to their respective intervention groups (i.e. almond consumption or no nut consumption) 
was monitored via self-reported intake as well as by analyzing their erythrocyte 
membranes for lipids and flavonoids at baseline and 12 weeks after the intervention.  
The lipid extracts from participant
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Rose and Oklander (29) and were analyzed by a shotgun lipidomics approach (J Dhillon, 
CR Ferreira, TJP Sobreira, unpublished data). The most informative lipids identified 
through the lipidomics scans and nut flavonoids reported in literature were combined into 
two MS methods i.e. single ion monitoring (SIM) and multiple reaction monitoring 
(MRM) using a triple quadrupole mass spectrometer. Data obtained from the targeted 
SIM and MRM methods were analyzed via univariate (volcano plots) and multivariate 
(PCA) statistics using Metaboanalyst (version 3.0, 2015) (30). The performance of the 
different m/z values and their combinations and ratios was evaluated by receiver 





4.4.6 Statistical analysis 
We conducted two analyses, a primary intention-to-treat analysis followed by a 
secondary analysis of participants compliant to their respective intervention groups. Both 
analyses used a linear mixed model with time, intervention group and a time-by-
intervention group interaction as factors for all absolute values of outcomes. An 
additional linear mixed model analysis on the change in outcomes as opposed to absolute 
values was also performed. In each analysis, when significant interactions were observed, 
pairwise comparisons with Bonferroni correction were carried out. Age range, sex and 
BMI range were also considered as between-subject factors for all the tests but there were 
no effects of the aforementioned factors on any of the outcomes.  
The sample size calculations for this study were based on detection of a 7% 
difference in visceral fat between groups with 80% power and a 2-tailed alpha of 0.05.  
Complete data were required from forty participants per group.  
Between-group differences were assessed at baseline by using independent-
samples t tests. Categorical outcomes were assessed using chi-square tests. The alpha 
level was set at 0.05. SPSS (version 22, 2013, SPSS Inc.) was used for all the statistical 




Eight-six participants enrolled in the study, but 7 withdrew during the intervention 
(Figure 4-1). The attrition rates were 7% for the AED group and 9.3% for the NFD group 





intervention groups at 12 weeks (P=0.69). The baseline characteristics of all participants 
are described in Table 4-1. There were no significant differences in the baseline 
characteristics of participants between groups. 
 
4.5.2 Compliance to energy restriction 
The energy-restriction compliance rates were 65.1% for the AED group and 
67.4% for the NFD group at 12 weeks. There were no significant differences in 
compliance to energy-restriction as assessed by the dietary intake data and weight loss 
between the AED and NFD intervention groups at 12 weeks (P=0.82). 
 
4.5.3 Compliance to intervention groups 
Data from 24-hour recalls indicated that total energy, carbohydrate, fat, protein 
and sodium intake decreased over time (P<0.05). The percentage of energy from fat and 
total MUFA, oleic acid, MUFA/SFA ratio, linoleic acid, total alpha-tocopherol, 
magnesium, copper and phytic acid intake (almonds are rich in these nutrients) was 
greater and percentage of energy from carbohydrate lower in the AED group compared to 
the NFD group at the end of the intervention (P<0.05) (Table 4-2). 
The shotgun metabolomics analysis conducted on 61 participants whose 
erythrocytes were collected indicated that specific ratios and combinations of mainly 
membrane lipids such as phosphatidylcholine and sphingomyelin were discriminatory of 
almond consumption from the nut-free diet at the end of the 12 week intervention in the 
AED group (J Dhillon, CR Ferreira, TJP Sobreira, unpublished data). However, 8 





into the opposite group indicating possible non-compliance to their respective 
interventions which was supported by dietary intake data. These participants, as well as 
those not compliant to the energy restriction, were excluded from the secondary 
compliers analysis. There were no significant differences in overall compliance based on 
weight loss and metabolomics analysis to the AED and NFD intervention groups at 12 
weeks (P=0.51). The baseline characteristics of the compliers are shown in Table 4-1. 
 
4.5.4 Anthropometric outcomes 
Body weight significantly decreased after the intervention in both analyses 
(P<0.05).There was no difference in weight loss between the AED and NFD groups in 
both the intention-to treat and compliers analyses (Table 4-3).  
Trunk and total fat mass and percentage significantly decreased after the 
intervention (P<0.05) in both analyses while trunk and total fat-free mass significantly 
decreased only in the compliers analysis and trunk and total fat-free mass percentage 
significantly increased after the intervention in both analyses (P<0.05) (Figure 4-2). The 
compliers analysis indicated a significantly greater decrease in trunk fat mass and 
percentage and total fat percentage and a significantly greater increase in the trunk and 
total fat-free mass percentage in the AED group compared to the NFD group (P<0.05) 
(Figure 4-2). 
 SAD and waist circumference significantly decreased after the intervention in 
both analyses (P<0.05). No significant differences were observed between the AED and 





 VAT predicted using both models significantly decreased after the intervention 
(P<0.05) in both analyses (Table 4-3). Although there was a trend for greater VAT loss in 
the AED group compared to the NFD group (Model 1: P=0.097) in the compliers 
analysis, this difference was not statistically significant (Table 4-3). Even though VAT 
model 2 was validated only for women, it strongly correlated with VAT model 1 for both 
men (r=0.941, P<0.0001) and women (r=0.923, P<0.0001) (Baseline correlations shown).  
 Resting systolic blood pressure significantly decreased after the intervention 
(P<0.05) while resting diastolic blood pressure remained unchanged for all participants. 
However, resting diastolic blood pressure significantly decreased in the AED group after 
the intervention (P<0.05) but not in the NFD group for participants compliant to the 
intervention (Table 4-3). Twenty-four hour ambulatory systolic and diastolic blood 
pressures remained unchanged at the end of the intervention in both analyses. In general, 
ambulatory blood pressure readings were significantly higher during waking hours i.e. 
from 8 am to 11 pm (systolic: 123.5 ± 0.6 mmHg, diastolic: 73.9 ± 0.46 mmHg) 
compared to sleeping hours i.e. 11 pm to 8 am (systolic: 113.5 ± 1.04 mmHg, diastolic: 
64.08 ± 0.94 mmHg) (P<0.05). 
 
4.5.5 Serum lipids, insulin and glucose 
Fasting serum insulin, triglycerides, total cholesterol, HDL and LDL cholesterol 
remained unchanged after the intervention while fasting glucose increased significantly 
after the intervention regardless of intervention group (P<0.05) (Table 4-3). In the 
compliers analysis, fasting glucose remained unchanged after the intervention in both 





4.5.6 24-hour free living appetite ratings 
Twenty-four hour hunger, desire to eat and prospective consumption ratings 
significantly decreased at the end of the intervention (P<0.05) with no difference between 
the AED and NFD groups (Table 4-3). Fullness ratings remained unchanged at the end of 
the intervention (Table 4-3). In the compliers analysis, hunger, desire to eat and fullness 
ratings followed the same trend as in the intention-to-treat analysis but prospective 
consumption ratings remained unchanged at the end of the intervention (Table 4-3). 
 
4.5.7 Almond palatability and acceptance 
The almond palatability ratings significantly decreased after the intervention (-
4.81 ± 2.2, (FACT scale units) P<0.05) while the almond acceptance ratings remained 
unchanged (-0.29 ± 0.28, (gLMS units) P =0.308) for participants in the AED group in 
the intention-to-treat analysis. The compliers analysis indicated no change in almond 
palatability ratings after the intervention (-3.8 ± 2.8, P =0.194) and the almond 
acceptance ratings remained unchanged as well (-0.16 ± 0.33, P=0.632). 
 
4.5.8 Activity energy expenditure 
Average activity energy expenditure was significantly higher on weekdays (0.7 ± 
0.04 kcal/minute) compared to weekend days (0.59 ± 0.05 kcal/minute, P<0.05) but 







The present study had several important findings. Despite similar weight loss with 
the two diets, almond consumption was associated with significantly greater proportional 
improvements in overall body composition and greater fat loss in the trunk area in 
compliant participants. Estimates of trunk fat (DEXA) are typically strongly correlated 
with abdominal visceral fat (r=0.86-0.89) (31), hence a reduction in trunk fat could 
reduce metabolic disease risk. One possible explanation for the greater fat loss with 
almond consumption stems from their high unsaturated fat content. Unsaturated fats have 
high fat oxidation rates which can preferentially reduce visceral fat (7).  
Although we did not see a statistically significant difference in VAT loss between 
the two diets, there was trend for greater reduction in VAT with almond consumption 
when assessed using models that took into account DEXA estimates of trunk fat and 
other measures of central obesity such as SAD and waist circumference. To our 
knowledge two nut-based interventional trials have examined VAT directly and found 
conflicting results (32,33). While one trial in overweight diabetic individuals observed 
that walnut consumption led to significant reductions of fat in both visceral and 
subcutaneous depots (33), the other trial in individuals with metabolic syndrome found 
no reduction in visceral or subcutaneous adipose tissue (assessed by MRI) with pistachio 
consumption for 24 weeks (32). Although the walnut trial was conducted in the context 
of weight maintenance, participants still lost weight. Hence, nut consumption in the 
context of weight loss might have greater effects on VAT loss.  Nut-specific effects are 
also possible though for most clinical outcomes and similarities are generally greater than 





 Our intervention demonstrated a decrease in resting systolic BP in both groups, 
but only the almond-enriched diet was associated with a reduction in resting diastolic BP 
(-3.6%) in compliant participants. Our findings are in contrast to the preponderance of 
clinical evidence that suggests no effect of tree nuts on resting BP in individuals without 
prevalent CVD (34). Similar reductions in diastolic BP have been observed with peanut 
consumption but only in individuals with elevated BP at baseline (20). Moreover, in the 
PREDIMED trial, consumption of a nut-based Mediterranean diet for one year led to a 
decrease in 24-hour ambulatory systolic and diastolic BP but only in high CVD risk 
individuals (35).  It is possible our findings reflect the use of almonds under energy-
restricted, weight loss conditions which could augment reductions of diastolic blood 
pressure (36).   
In the present study, serum insulin and glucose remained unchanged with almond 
consumption for 12 weeks. Although nut consumption has positive effects on glycemic 
control (37), the long term effects are typically more favorable in prediabetic (38), and 
diabetic individuals (39) or those with metabolic syndrome (40). In addition, there were 
no changes in serum triglycerides, total cholesterol, HDL and LDL cholesterol with 
almond consumption. The participants in our study were healthy adults with overweight 
and obesity with no other CVD risk factors and the preponderance of nut-based evidence 
shows the greatest improvements in blood cholesterol in individuals with high LDL 
cholesterol and those with low BMI, and improvements in triglycerides in individuals 
with hypertriglyceridemia (41). Moreover, these improvements were observed with an 
average daily nut consumption of 67g whereas the participants in our study consumed 





The satiating effects of almond consumption in acute feeding trials are well 
documented (7). These properties have important implications for weight management as 
they can translate into strong dietary compensatory responses. Whether these satiating 
effects can be sustained chronically has yet to be established. In this 12-week clinical 
weight loss trial, almond consumption reduced 24-hour hunger and desire to eat ratings to 
a similar degree as the nut-free diet. But it is important to note that both intervention 
groups underwent structured dietary counseling to make healthier and satiating food 
choices.  
Another consideration in long-term feeding studies is that of monotony effects 
arising as a result of repeated daily consumption of specific foods (42). This is important 
as it might undermine compliance to a dietary recommendation to increase consumption 
of a given food. In our study, almond palatability ratings significantly decreased over 
time but remained within acceptable range i.e. from over strongly palatable at baseline to 
over moderately palatable at the end of the intervention. However, individuals compliant 
to the intervention demonstrated no decline in almond palatability ratings (rated 
consistently over strongly palatable) suggesting that these individuals may have been 
more resistant to the monotony effects and hence more compliant.    
In conclusion, incorporating modest quantities of almonds in a 12 week weight-
loss regimen led to significant reductions in weight and improvements in body 
composition and blood pressure in healthy adults with overweight and obesity. The 
clinical benefits of moderate almond consumption among individuals with or at a high 





findings indicate positive health effects among overweight, but otherwise healthy adults 
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Sex [n (%)]     
         Male 11 (25.6) 10 (23.3) 8 (34.8) 7 (25.9) 
         Female 32 (74.4) 33 (76.7) 15 (65.2) 20 (74.1) 
Age (y) 31.05±12.91 31.77±13.15 33.57±12.86 34.93±13.11 
BMI (kg/m2) 29.91±3.2 30.97±4.48 30.33±3.22 30.56±3.87 
BMI Category [n 
(%)] 
    
    Overweight 
(BMI: 25-29.9 
kg/m2) 
23 (53.5)  21 (48.8) 10 (43.5) 13 (48.2) 
    Obese (BMI: 
30-40 kg/m2) 
20 (46.5) 22 (51.2) 13 (56.5) 14 (51.8) 




88.05±8.69 90.23±9.80 90.09±8.69 90.21±9.38 
SAD (cm) 21.91±2.65 22.24±3.09 22.63±2.81 22.41±3.01 
Resting systolic 
BP 
123.11±11.39 121.12±8.62 124.67±9.25 121.19±8.15 
Resting diastolic 
BP 
75.22±8.79 73.85±7.15 74.52±6.45 76.32±9.63 
Total fat mass 
(kg) 
31.67±7.49 33.09±8.93 31.63±8.56 32.04±8.67 
Trunk fat mass 
(kg) 
16.14±4.53 16.96±5.42 16.63±4.81 16.71±5.16 
Total fat-free 
mass (kg) 
50.08±9.62 50.60±8.81 50.82±9.78 49.26±9.63 
Trunk fat-free 
mass (kg) 
22.47±4.41 22.84±3.72 22.82±4.54 22.34±3.87 
VAT (model 1)2 92.42±43.95 106.62±51.01 104.59±45.14 114.83±42.69 














Mean ± SD (all such values), 2 ITT analysis-   	 
  
analysis- AED: n=20, NFD: n=23. - Refers to not assessed. There were no statistically 
significant differences in outcomes between the 2 intervention groups at baseline 






































Energy1 (kcal) -233.31±102.29 -292.28±105.09 
Carbohydrate1 (g) -39.35±15.93 -23.05±16.37 
Fat1 (g) -3.81±5.41 -19.02±5.56 
Protein1 (g)  -11.18±5.50 -9.02±5.64 
Dietary Fiber (g) 1.40±1.55 0.59±1.59 
% energy from carbohydrate2 -3.46±2.24 3.46±2.30 
% energy from protein -1.20±1.22 1.04±1.26 
% energy from fat2 3.67±1.88 -5.02±1.931 
Total MUFA2 (g) 2.87±2.05 -8.16±2.101 
% energy from MUFA1,2 (g)  4.06±.82 -2.52±.84 
Total PUFA (g) .47±1.76 -4.29±1.81 
Total SFA1 (g) -6.39±2.27 -5.40±2.33 
MUFA/SFA ratio1,2 .77±.12 -0.03±.13 
PUFA/SFA ratio1 .31±.13 0.11±.14 
Oleic acid2 (g) 3.26±1.95 -7.63±2.011 




Magnesium2 (mg) 51.63±20.091 -14.89±20.65 
Copper2 (mg) 0.13±.098 -0.24±.101 
Phytic Acid2 (mg) 203.39±92.541 -74.97±95.07 
Sodium1 (mg) -400.29±269.87 -417.22±277.25 
Values are mean ± SEM obtained from a linear mixed effects model with time as within-
subject factor and intervention group as between subject factor. 1 P<0.05 over 12 week 































Body weight1 (kg) -2.22±0.46 -1.09±.46 -3.55±0.47 -2.46±0.44 
VAT (model 1)1,2 
(cm2) 
-4.31±1.48 -1.40±1.49 -8.19±1.81 -3.99±1.68 
VAT (model 2)1 
(cm2) 
-9.04±1.31 -6.69±1.33 -12.82±1.60 -9.23±1.48 
Waist 
circumference1 (cm) 
-4.36±1.78 -2.57±1.77 -3.24±0.44 -2.54±0.41 
SAD1 (cm) -0.797±0.15 -0.59±0.15 -1.15±0.18 -0.88±0.16 
Resting BP (mmHg) 
       Systolic BP1  -3.11±1.35 -1.56±1.35 -3.23±1.85 -2.20±1.70 
       Diastolic BP -1.07±0.92 0.07±0.92 -2.71±1.151,3 0.815±1.06 
Fasting blood profile 
(mg/dL) 
      Insulin  -1.17±2.32 -2.79±2.33 -3.54±3.81 -3.22±3.52 
      Glucose4 3.20±1.80  2.57±1.81 2.61±2.63 4.41±2.43 
      Triglycerides -18.10±11.43 -7.57±11.47 -17.65±18.70 -15.11±17.26 
      Total   
      cholesterol 
-2.43±3.54 2.57±3.56 -1.61±4.5 2.26±4.15 
      HDL 2.65±1.40 0.57±1.41 1.99±2.03 1.69±1.87 
      LDL -0.79±2.96 1.60±2.98 .212±4.14 1.22±3.82 
Appetite ratings  
(mm) 
    Hunger1 -3.15±2.61 -6.07±3.81 -3.42±3.54 -6.71±4.12 
    Fullness 0.09±2.89 1.88±4.19 0.25±3.97 1.89±4.60 
    Desire to eat1 -5.23±2.69 -5.63±3.93 -6.76±3.59 -4.87±4.19 
    Prospective    
    Consumption4 
-3.45±2.47 -7.02±3.57 -3.29±3.41 -6.92±3.94 
Values are mean ± SEM obtained from a linear mixed effects model with time as within-
subject factor and intervention group as between subject factor. 1 P<0.05 over time (12 




- AED: n=20, NFD: n=23, 3 P<0.05 AED vs. NFD, 4 P<0.05 over 



























Figure 4-2: Mean change in total and trunk A) fat mass and B) fat-free mass C) fat mass 
percent and D) fat-free mass percent over the 12 week weight loss intervention in the 
AED and NFD groups.  
Values are mean ± SEM obtained from a linear mixed effects model with time as within-
subject factor and intervention group as between subject factor. * P<0.05 over time (12 
week intervention). ** P<0.05 AED vs. NFD groups. ITT analysis-AED: n=43, NFD: 
  	
  
- AED: n=23, NFD: n=27. ITT: Intention-to-treat analysis. 





CHAPTER 5. EFFECTS OF ALMONDS ON COGNITIVE FUNCTION AND THE 
POST LUNCH DIP IN ENERGY-RESTRICTED OVERWEIGHT AND OBESE 
ADULTS 
Dhillon, J., Tan S.Y. and Mattes R.D.  Effects of almond consumption on the post-lunch 
dip and short-term cognitive function in energy-restricted overweight and obese adults. 
Br. J. Nutr  (submitted on June 22, 2016) 
The manuscript has been submitted to the British Journal of Nutrition and formatted 
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5.1 Abstract 
The post-lunch dip in cognition is a well-established phenomenon of decreased 
alertness, memory and vigilance after lunch consumption. Lunch composition reportedly 
influences the post-lunch dip. Moreover, dieting is associated with cognitive function 
impairments. The negative effects of dieting have been reversed with nut-supplemented 
diets. The aims of this study were to 1) evaluate the acute effect of an almond-enriched 
high fat lunch or high carbohydrate lunch on the post-lunch decline in cognitive function 
and 2) evaluate the effects of chronic almond consumption as part of an energy-restricted 
diet on the memory and attention domains of cognitive function. Eighty-six overweight 
and obese adults were randomized to consume either an almond-enriched diet or a nut-





randomized to receive either a high fat lunch (A-HFL) (>55% energy from fat, almonds 
contributing 70-75% energy) or a high carbohydrate lunch (HCL) (>85% energy from 
carbohydrates) at the beginning and end of the intervention. Memory and attention 
performance indices such as concentration and qualitative performance decreased after 
lunch consumption (P<0.05). The A-HFL group had smaller declines in memory scores 
compared to the HCL group (P<0.05). Both lunch groups had similar declines in 
attention. Hence, consumption of an almond-enriched lunch reduced the post-lunch dip in 
memory. However, the macronutrient composition of the lunch did not affect the post-
lunch dip in attention. Moreover, memory and attention performance indices increased 
after the intervention (P<0.05). But, there were no additional improvements in these 
outcomes with almond supplementation. 
 
5.2 Keywords 
Cognitive function: Cognition: Post-lunch dip: Almonds: Nuts: Attention: Memory 
 
5.3 Introduction 
The post-lunch dip in cognitive performance is a well-established phenomenon of 
decreased cognitive function in the early afternoon hours typically after lunch 
consumption(1). It is thought to begin approximately one hour after the start of lunch 
consumption. During the post-lunch dip, memory and vigilance are the most severely 
affected domains, and decreased mood, alertness and anxiety are also reported(2,3). These 
symptoms may negatively affect performance and increase personal and societal 





lunches leading to slower(6,7) but more accurate(7) responses than low-fat lunches. High-
carbohydrate meals have a sedative effect promoting drowsiness in females and calmness 
in males(8). Other studies have reported longer reaction times after consumption of 
lunches higher in fat or carbohydrate than normal(9). There is heterogeneity to these 
responses in terms of age. For example:    	 
  show impaired cognitive 
performance after a high-carbohydrate lunch whereas adults < 40 years do not(8). 
However, in healthy young adults, tasks that demand greater cognitive function are more 
sensitive to nutrient manipulations(10). The unique nutrient profile of almonds, which is 
lower in carbohydrate and high in protein and unsaturated fats, may lessen this post-lunch 
dip in young and middle aged adults. If almonds are able to ameliorate the post-lunch dip, 
they can enhance productivity (e.g., accuracy of written tasks) and safety (staying awake 
while driving or working with machines). 
Nut consumption over the long-term is also positively associated with cognitive 
performance. In a five year prospective cohort study, the difference in cognitive 
performance between the lowest and highest consumers of nuts was equivalent to a 5 to 8 
year lesser age-related difference in cognitive function(11). In addition, individuals that ate 
the most nuts had no cognitive decline over the 5 year study period (amount and types of 
nuts unspecified)(11). In the PREDIMED study, walnut consumption was associated with 
increased working memory in adults aged 55-80 years(12)        
Study revealed higher long-term nut intake was associated with better cognitive 
outcomes(13). In addition, women who consumed more than 5 servings of nuts per week 
had higher global cognition scores than non-consumers; the difference in scores was 





data from interventional trials in humans to establish causation. In one trial, consumption 
of brazil nuts (one nut per day) for 6 months improved verbal fluency and constructional 
praxis in older adults with mild cognitive impairment(14). The only interventional study to 
date conducted in young adults observed an 11% increase in inferential verbal reasoning 
after consumption of 60g walnuts/day for 8 weeks(15). They observed no changes in non-
verbal reasoning and memory scores.  
The process of dieting to lose weight is associated with cognitive function 
impairments(16) that could be a result of food restriction, anxiety related to maintaining a 
weight loss regimen or preoccupying thoughts of hunger and desire to eat(17) and body 
esteem(18,19). Negative effects of dieting on cognitive performance have been reversed 
with nut-supplemented diets higher in fat and lower in carbohydrate(20). Hence, learning 
and memory may also be enhanced with the inclusion of almonds during weight loss. 
The beneficial effects of nuts on cognitive performance in the long-term are likely 
due to the improvements in cardiovascular risk factors such as lipid profile, arterial 
compliance, glucoregulation, oxidative stress, blood pressure and inflammation, with 
subsequent improvements in endothelial function and cerebral vascular function(21). Nut-
rich Mediterranean diets reportedly increase brain-derived neurotrophin (BDNF) 
concentrations in people with depression(22). High concentrations of BDNF are associated 
with retention of memory and reduced cognitive decline(23 25). Nuts are high in 
neuroprotective compounds such as Vitamin E, folate, melatonin, alpha linoleic acid 
(ALA) (walnuts) and polyphenols(25). Although most tree and ground nuts generally have 
similar nutrient profiles, some nut specific properties are purported to play a role in 





have been widely studied in animal models(26,27) and in vitro(25), possibly because of their 
previously established anti-oxidative and anti-inflammatory effects. The effects of 
almonds on improving memory(28) in rats have been associated with their cholinergic, 
anti-cholinesterase and cholesterol lowering properties(25,28).  
The purpose of this study was two-fold. The first aim was to determine the post-
lunch changes in cognitive function with almond consumption at lunch compared to a 
high-carbohydrate control lunch. We hypothesized that inclusion of almonds in a midday 
meal will ameliorate the post-lunch decline in memory and attention compared to a high 
carbohydrate control meal by lowering the percentage of dietary energy from 
carbohydrates and increasing the percentage of energy from fat. The second aim was to 
evaluate the effects of almond consumption as part of an energy-restricted diet on 
cognitive function compared to a nut-free diet matched on energy-restriction (control). 
We hypothesized that inclusion of almonds in an energy-restricted diet will improve the 




Eighty-six healthy overweight or obese adults (21 men and 65 women) 
participating in an almond weight-loss clinical trial were recruited. Eligibility criteria was 
as follows: age of 18 60 years, BMI of 25-40 kg/m2, no nut allergies, willingness to 
consume study foods and comply with the study protocol, no endocrine or metabolic 
disorders, non-smokers and consistent diet and activity patterns. This study was 





registered on ClinicalTrials.gov (registration number: NCT02360787). All procedures 
involving human subjects were approved by the Purdue Institutional Review Board. 
Participants were recruited via public advertisements. Those meeting the eligibility 
criteria were contacted to schedule a screening visit. Participants provided written 
consent at the beginning of the screening session and were compensated for their time in 
the study.  
 
5.4.2 Intervention 
The study was a 12-week randomized, controlled, parallel-arm weight loss trial. 
In brief, participants were randomized into one of two energy-restricted study arms: 
Almond enriched diet (AED) or nut-free diet (NFD) groups. Both groups received dietary 
counseling to reduce energy intake to achieve 2092 kJ/day (500 kcal/day) deficits to 
support weight loss. Weekly energy and nutrient analyses using 24-hour food recalls 
were conducted to determine the part   	
  	   
recommendations.  
Forty-three participants were randomized into each of the AED and NFD groups. 
Participants in the AED group were asked to consume dry-roasted, lightly salted almonds 
providing 15% of the energy in their individualized energy-restricted diet. Energy from 
almonds was accounted for during dietary modeling so that a 2092 kJ/day (500 kcal/day) 
deficit was achieved. Participants in the NFD group were asked to avoid all nuts and nut 
products during the intervention period. Cognitive function outcomes were assessed at 






5.4.3 Test meals for post-lunch dip assessment 
Participants were randomized into either an almond-enriched high fat lunch group 
(A-HFL), or a high-carbohydrate lunch group (HCL) at the beginning of the study. Lunch 







energy intake at lunch was determined from the What we eat in America, NHANES 
2011-2012 survey that reports the percentage of energy intake at lunch according to sex 
and age(29). Participants in the HCL meal were fed a combination of spaghetti in tomato 
sauce (SpaghettiOs, Campbell, USA), white bread, jelly and apple juice providing greater 
than 85% energy from carbohydrate. Participants in the A-HFL meal were fed almonds 
with some Spaghetti Os and/or white bread, jelly and apple juice providing greater than 
55% energy from fat. The almonds provided 70-75% energy in the A-HFL meal. An 
example of a sample lunch is provided in Table 5-1. Participants were instructed to eat 
the entire test meal. Cognitive function outcomes were assessed immediately after lunch 
and 30-35 minutes later. In addition, the post-lunch dip assessments were performed at 
baseline and at the end of the 12-week intervention. 
 
5.4.4 Cognitive function test protocol 
The cognitive function test protocol is shown in Figure 5-1.  Participants arrived 
in the laboratory in a fasted state for measurement of other variables pertaining to the 
almond weight loss study such as body weight, body fat, blood pressure, serum insulin 
and glucose etc. (reported elsewhere). Instead of assessing cognitive outcomes before 





lieu of the pre-lunch time point as there is some evidence that breakfast skipping is 
associated with negative cognitive consequences(30).  
After measurement of the aforementioned variables, participants were provided 
with a midday meal according to their randomized lunch group (A-HFD or HCL). They 
were given 15 minutes to eat their meal after which they were taken into a quiet room for 
cognitive function testing. Testing included memory and attention domains of cognitive 
function. The tests for memory: immediate memory, delayed memory and verbal list 
recognition tests were adapted from the repeated battery for the assessment of 







test of attention(32) respectively. 
 In the immediate memory test, participants were read a list of 10 words 
immediately after lunch prior to the onset of the post-lunch dip. They were asked to 
remember and recall the words after 2 minutes. The number of correct responses was 
recorded. In the delayed memory test participants were asked to recall the same 10 words 
read to them and record them on a sheet of paper 35 minutes after lunch consumption. 
The number of correct responses was tallied.  
In the attention test, participants were asked cross out the letter d accompanied 
with 2 dashes (above the letter d, below the letter d or one dash above and one below the 
letter d) on a recording blank with 14 lines of 47 letters comprised of either d or p with 1, 






  iate targets) were 
recorded. This test was used to assess quantitative performance (total number of items 





errors, TNE) and concentration performance (the total number of correct items marked 
minus errors of commission, CP). The attention tests were conducted immediately- and 
30 minutes after lunch.  
Finally, the verbal list recognition test      	 

 
to recall the 10 words read out to them immediately after lunch. The tester read out a list 
of 20 words and participants had to acknowledge verbally which words were present in 
the initial list. The correct responses were marked.  
  
  	      e used to fill in the 30 
minute interval after lunch to ensure that participants did not fall asleep. Participants were 
asked to cross out different combinations of irrelevant letters with dashes over 28 
minutes. These tests were not graded. 
 
5.4.5 Statistical analysis 
A linear mixed model analysis was performed on the correct responses obtained 
 	       	   	   
attention (i.e., total number of items processed, concentration performance, quantitative 
performance and qualitative performance. The intervention period (before vs. after) and 
the lunch period (immediately after vs. 35 minutes after) were used as within-subject 
factors and the intervention and lunch groups as between-subject factors. The correct 
responses from the verbal list recognition test were analyzed using a linear mixed model 
with intervention period as the within-subject factor and the intervention and lunch 
groups as between-subject factors. An additional linear mixed model analysis on the 





and BMI range were also considered as between-subject factors for all the tests. When 
significant interactions were observed, pairwise comparisons were carried out with 
Bonferroni correction.  
Between-group differences were assessed at baseline by using independent-
samples t tests. Pearson statistics were used to determine correlations. The alpha level 
was set at 0.05. SPSS (version 22, 2013, SPSS Inc.) was used for all the statistical 
analyses. OriginPro (version b9.3.226, 2016, OriginPro Corporation) was used to graph 
the data. Data are reported as means and standard errors (SEM). The sample size 
calculations for this study were based on visceral fat which was one of the primary 




The baseline characteristics of all participants are reported in Table 5-2. Of the 86 
participants that were enrolled in the study, 7 withdrew during the intervention. Four 
participants withdrew due to non-compliance with the dietary protocol, 1 withdrew due to 
illness not related to the study, 1 female participant withdrew because of pregnancy and 1 
withdrew due to lack of time to devote to the study. There were no significant differences 
in attrition between the AED and NFD intervention groups at 12 weeks.  
 
5.5.2 Compliance to intervention 
Total energy intake decreased in both AED (-976.17±427.98 kJ) and NFD groups 





energy from fat (36.62±1.42 vs. 29.36±1.46 (%, AED vs. NFD) and total MUFA 
(27.70±1.43 vs. 15.43±1.47 g), total alpha-tocopherol (15.15±0.8 vs. 6.43±0.82 mg), 
magnesium (311.98±16.85 vs. 245.36±17.31 mg), and phytic acid (850.86±64.13 vs. 
614.42±65.89 mg) intake were greater and the percentage of energy from carbohydrate 
(46.34±1.65 vs. 51.93±1.70 %) was lower in the AED group compared to the NFD group 
at the end of the intervention (P<0.05). These nutrient intake patterns reflect the nature of 
the dietary intervention.  
 
5.5.3 Cognitive function outcomes 
Memory outcomes 
Memory scores did not differ between the A-HFL and HCL meals immediately 
after lunch. However, memory scores decreased significantly 35 minutes after 
consumption of lunch in both groups (P<0.05). The A-HFL meal was associated with a 
significantly smaller decline in memory score 35 minutes after lunch consumption 
compared to the HCL meal (P<0.05) (Figure 5-2).  
In addition, there were no significant differences between the mean number of 
correct words recorded immediately after lunch (immediate memory score) and mean 
number of correct words recorded 35 minutes after lunch (delayed memory score) 
between the AED and NFD groups at baseline. Both memory scores increased 
significantly after the 12-week weight loss intervention period (P<0.05), but the 







Verbal list recognition (VLR) outcomes 
There was no significant difference in the VLR score between the A-HFL and 
HCL meals 35 minutes after lunch consumption. In addition, there was no significant 
differences between the mean number of words correctly recognized verbally (VLR 
score) between the AED and NFD groups at baseline. Although the VLR score increased 
after the 12-week weight loss intervention in both groups (AED: 0.47±0.25, NFD: 
0.63±0.25, no. of words, P<0.05), the difference between the groups was not significant. 
 
Attention outcomes 
The performance indices i.e. concentration performance (CP), quantitative 
performance (TN) and qualitative performance (TNE) did not differ between the A-HFL 
and HCL meals immediately after lunch. However, while CP and TNE decreased 
significantly 35 minutes after consumption of lunch (P<0.05) (Figure 5-4), TN decreased 
significantly 35 minutes after consumption of lunch only after the weight loss 
intervention (Figure 5-4). There were no significant differences in the performance 
indices between the AED and NFD groups at baseline. Although the performance indices 
increased after the weight loss intervention (P<0.05), the difference between the groups 
was not significantly different (Figure 5-5). 
Participants aged 18-39 years had higher scores for all performance indices than 
participants aged 50-60 years regardless of intervention group and post-lunch dip group 
(P<0.05, data not shown). Age was also moderately correlated with all performance 
indices regardless of group. The correlation coefficients between age and performance 





 There was no effect of sex, weight category (BMI) or amount of weight loss on 
memory, VLR or attention outcomes.  
 
5.6 Discussion 
The present study confirmed the presence of a post-lunch dip as evidenced by a 
decline in the memory and attention performance domains of cognitive function 35 
minutes after lunch consumption. An important finding of the study was the effect of 
lunch composition on cognitive function. As hypothesized, the almond enriched high fat 
lunch was followed by smaller declines in memory compared to the high carbohydrate 
lunch. This acute effect of almond consumption may be attributable to their high fat and 
fiber content and lower carbohydrate content. Almond consumption has previously been 
shown to have a moderating effect on postprandial blood glucose concentrations(33,34). Fat 
and fiber can lower postprandial glycemia by delaying gastric emptying(35) and intestinal 
transit time(36) respectively. Lower than normal blood glucose concentrations impair 
cognitive function(37). Hyperglycemia has also been associated with impaired 
performance but primarily among individuals with diabetes(38). In one study, a low 
glycemic index breakfast improved memory performance over a high glycemic index 
breakfast indicating that the rate of glucose release into the circulation may be 
responsible for these effects(39). Consumption of almonds with a meal can reduce the 
glycemic impact of carbohydrate, thereby maintaining optimum blood glucose 
concentrations for memory tasks.  
Dietary factors other than lunch composition can influence the post lunch dip as 





cognitive function after lunch. Larger lunches are associated with an increased number of 
errors in selective attention(40) and decreased cognitive performance in general(41) 
compared to smaller lunches. In the present study, the amount of food given to 
participants was based on 23-25% of their estimated daily energy requirements. This is in 
line with customary intake levels in the population(29), so was ecologically valid though 
perhaps not a test of the extent of the effect.  Others argue that the post-lunch dip is more 
attributable to endogenous rhythms(42) or is a consequence of conditioned lunch effects(43) 
rather than being causally link to lunch composition or size. For example, some studies 
have observed differences in cognitive function between late morning and early afternoon 





(2,44) but  individuals who ate lunch had a 
greater post-lunch dip in sustained attention compared to the lunch skippers(2). Although 
we did not control the time at which lunch was provided to participants, there are limited 
data indicating that the post-lunch dip in attention and reaction to a new stimulus is not 
affected by the time at which lunch is eaten(2,44). Other causes of the post-lunch dip in 
cognitive function have been proposed including insulin surges(45) increased cortisol (46), 
or serotonin concentrations(8) among others.  
  In our study, almond consumption at lunch did not ameliorate the post-lunch dip 
in attention. However, the attention domain of cognitive function may not be as sensitive 
to macronutrient manipulation compared to the memory domain(47). 
This twelve week randomized weight loss trial improved memory and attention 
performance in overweight and obese energy restricted adults. This is contrary to what 
has been observed in most(17,18,48) but not all(20) studies on dieting adults. The 





participants having undergone dietary counseling to make healthier choices and lose 
weight. However, in spite of restricting the testing occasions to before and after the 12 
week intervention, there is a possibility of practice effects(49). There were no additional 
improvements in memory and attention with almond supplementation. Although a 
previous nut-based trial has demonstrated improvements in working memory and speed 
of processing in energy restricted adults consuming nut-supplemented diets(20), this study 
did not have a control group. Hence, a comparison of the magnitude of improvements in 
cognitive function between a nut supplemented and a nut-free diet could not be made. 
Although the present study showed  no effects of BMI on cognitive function, a 
recently published study observed a protective effect of obesity on cognitive function in 
people aged 45 years and older, particularly in women(50). The lack of an effect noted 
here may be attributable to the absence of normal weight individuals for comparison. 
Interestingly, others have found a positive association between weight loss (over 12 
years) and cognitive decline in older adults. While this is contrary to the improved effects 
on cognitive function with weight loss observed in the present study, we did not 
exclusively recruit older people and our intervention may not have been long enough to 
observe these changes. We also did not find any BMI, age or gender interaction effects 
on cognitive function. However, we did find a negative association between age and 
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        	     
decline with ageing is a common occurrence(51). 
In conclusion, almond consumption acutely ameliorated the post-lunch dip in 
memory and may be an effective means to maintain memory following the midday meal. 





in cognitive function outcomes with weight loss. Nevertheless, literature indicates that 
almond consumption enhances satiety(52) and reduces hunger and desire to eat(33), 
properties that may minimize hunger-related thoughts that can acutely impair cognitive 
function in dieters(17).  
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Table 5-1: Nutrient composition of a sample lunch provided to a 28 year old male 
participant on a 7431.2 kJ/day (1800 kcal/day) diet in both lunch groups 
 Almond enriched high fat 
lunch (A-HFL) 
High carbohydrate lunch 
(HCL) 
Food items* 53g almonds (75% energy 
of lunch) 
    	 
 
 
1 cup water 
 
   	 
 
 
1 slice white bread (25g) 
1 tbsp. jelly 
½ cup apple juice 
1 cup water 
Energy (% daily 
intake) 
26 26 
Carbohydrate (%) 31 86 
Fat (%) 56 4 
Protein (%) 13 10 
* The study was not a crossover design, but this is exemplary of two meals for 



















Intervention groups Post-lunch dip experimental groups 
Almond-enriched 
diet (AED) n=43 
Nut-free diet (NFD) 
n=43 
Almond-enriched high 
fat lunch (A-HFL) n=43 
High carbohydrate 
lunch (HCL) n=43 
 Mean SD Mean SD Mean SD Mean SD 
         
Age (y) 31.05 12.9 31.77 13.15 30.30 12.89 32.51 13.08 
Body weight (kg) 82.79 12.9 84.71 14.12 84.38 14.50 83.12 12.51 
BMI (kg/m2) 29.91 3.20 30.97 4.48 30.93 4.42 29.94 3.29 
         
 n % n % n % n % 
Sex  
         Male 11  25.6 10 23.3 9  20.9 12 27.9 
         Female 32  74.4 33 76.7 34 79.1 31 72.1 
Age range 
     18-39 y  32  74.4 31 72.1 33 76.7 30 69.7 
     40-49 y 5  11.6 4  9.3 3  7.0 6  14.0 
     50-60 y 6  14.0 8  18.6 7  16.3 7  16.3 
Weight Category  
     Overweight  
      (BMI: 25-29.9 kg/m2) 
23  53.5 21 48.8 21 48.8 23 53.5 
     Obese  
      (BMI: 30-40 kg/m2) 









Figure 5-2: Mean change in memory scores immediately after lunch and 35 minutes after 
lunch consumption in the almond enriched high fat lunch (A-HFL) and high carbohydrate 
lunch (HCL) groups before and after the 12-week intervention.  
Values are means and standard errors obtained from a linear mixed effects model with 
lunch period and intervention period as within-subject factors and lunch group and 
intervention group as between subject factors. * Significant differences for change in 
memory scores over lunch period (P<0.05). ** Significantly different between the A-
HFL and HCL groups (P <0.05). A-HFL: n=43; HCL: n=43.Values are means and 
standard errors. * Significant differences for change in memory scores over intervention 






Figure 5-3: Mean change in immediate and delayed memory scores before and after the 
12-week intervention in the almond enriched diet (AED) and the nut-free diet (NFD) 
groups.  
Values are means and standard errors obtained from a linear mixed effects model with 
intervention period and lunch period as within-subject factors and intervention group and 
lunch group as between subject factors. * Significant differences for change in memory 








Figure 5-4: : Mean change in performance indices immediately after lunch and 35 
minutes after lunch consumption in the almond enriched high fat lunch (A-HFL) and high 
carbohydrate lunch (HCL) groups before and after the 12-week intervention.  
Values are means and standard errors obtained from a linear mixed effects model with 
lunch period and intervention period as within-subject factors and lunch group and 
intervention group as between subject factors. * Significant differences for change in 
performance indices over the lunch period (P<0.05). CP: concentration performance; TN: 







Figure 5-5: Mean change in performance indices before and after the 12-week 
intervention in the almond enriched diet (AED) and the nut-free diet (NFD) groups 
immediately after lunch and 35 minutes after lunch consumption.  
Values are means and standard errors obtained from a linear mixed effects model with 
intervention period and lunch period as within-subject factors and intervention group and 
lunch group as between subject factors. * Significant differences for change in 
performance indices over the intervention period (P<0.05). CP: concentration 







CHAPTER 6. ASSESSING ALMOND CONSUMPTION COMPLIANCE BY FLOW 
INJECTION METABOLOMICS 
Dhillon, J., Tan S.Y. and Mattes R.D.  A shotgun fingerprinting approach to document 
compliance with an almond consumption intervention. Metabolomics (submitted on June 
30, 2016) 
The manuscript has been submitted to the Metabolomics journal and formatted according 
to the requirements of the journal. 
 
6.1 Abstract 
Introduction: Almonds are extremely rich sources of lipids and flavonoids and their 
consumption is associated with several health benefits. However, there are no known 
analytical methods to document compliance to almond consumption in the long run. 
Objective: To develop an analytical approach that identifies metabolic profiles 
associated with long-term almond consumption to ascertain compliance with prescribed 
consumption.  
Methods: A shotgun fingerprinting strategy was designed to isolate metabolic changes 
in erythrocytes after 12-wk almond consumption. Representative samples (pools) of 
erythrocytes from individuals consuming almonds or no almonds were screened by flow 
injection mass spectrometry. Data based on scan modes for shotgun lipidomics, and m/z 





m/z values detected in pooled samples were combined into single ion monitoring and 
multiple reaction monitoring methods intended for individual sample screening. 
Results: Out of the 243 values of m/z monitored by both methods, 5 ratios and 
combinations of specific ions with receiver operating characteristic (ROC) curves 
AUC>0.89 had sensitivity of 74.2% and specificity of 90%. Eight out of the 31 
participants (25.8%) in the almond group and 3 out of the 30 (10%) participants in the 
control group were misclassified by all 5 ratios.  
Conclusion: Ratios and combinations of specific ions mainly related to membrane lipids 
were discriminatory of almond consumption from the nut-free diet. The 
misclassifications observed as a result of ratio performance evaluation could be 
indications of possible non-compliance as supported by the dietary intake data. 
 
6.2 Keywords 
Almond Biomarkers; Human Erythrocytes; Metabolomics; Nuts; Shotgun Lipidomics 
  
6.3 Introduction 
Almond consumption is associated with several health benefits such as 
improvements in lipid profile, glycemic control and vascular health (Barbour et al. 2014; 
Kendall et al. 2010). In addition, despite their high energy content, almond consumption 
does not promote weight gain (Flores-Mateo et al. 2013) and recent evidence indicates 
that almonds may improve body composition (Hollis and Mattes 2007). Almonds are 
good sources of monounsaturated fatty acids (MUFAs), protein, fiber, arginine, vitamin 





aforementioned health benefits (Kendall et al. 2010) but characterization of their benefits 
requires additional clinical study. 
Assessing compliance to dietary interventions in long-term clinical trials is 
frequently problematic. Although self-reported measures of intake such as 24-hour food 
recalls and food frequency questionnaires are widely used, these are subjective measures 
of dietary intake (Johnson 2002) and only capture an imperfect snapshot of  an 
individual s dietary pattern. Compliance to long-term almond consumption is 
occasionally documented using plasma alpha-tocopherol (Hollis and Mattes 2007; Li et 
al. 2011). However, plasma alpha-tocopherol is more strongly associated with vitamin E 
supplement intake (Ascherio et al. 1992; Stryker et al. 1988) and might not reflect intake 
of vitamin E from dietary sources such as nuts (Kardinaal et al. 1995). Hence, there is a 
need to develop methods that can identify metabolic profiles associated with long-term 
almond consumption in order to ascertain compliance to an almond consumption 
prescription.  
Nutritional metabolomics is a relatively new domain of nutrition that can capture 
the phenotype of dietary exposure in biological samples (Scalbert et al. 2014). Although 
urine and blood plasma samples are commonly used in the application of nutritional 
metabolomics, red blood cells (erythrocytes) may reflect longer-term dietary intake 
(Catalán et al. 2013) since the average erythrocyte lifespan is between 70 to 140 days 
(Franco 2012). Because almonds are a rich source of lipids, it is reasonable to screen for 
diverse lipids in the erythrocytes of individuals chronically consuming almonds.  
Flow injection mass spectrometry (FIA-MS) is a simple, fast and informative 





metabolites that can be used for this purpose. It is based on the direct injection (without 
chromatographic separation) of crude lipid extracts on electrospray (ESI) ion sources. 
Targeted analysis by FIA-MS can be performed by screening for values of m/z or ion 
pairs related to specific metabolites or lipids. Untargeted analysis by FIA-MS can be 
performed by full mass scan or by shotgun lipidomics. Shotgun lipidomics takes 
advantage of neutral loss (NL) and precursor ion (PREC) scan mode experiments to 
profile diverse classes of lipids based on the fact that the lipid chemical structure is 
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fragment ions (detected by PREC experiments) or losses (detected by NL 
experiments)(Han and Gross 2005). However, because of ionization suppression, 
isotopic, isobaric and isomeric interferences likely occur during flow injection and may 
impair quantification accuracy, we did not quantify the lipids but rather used relative 
amounts of lipids and named this approach shotgun fingerprinting. This approach 
simplifies identification of relevant lipids by avoiding the necessity of internal standards, 
chromatographic separation and, by simplifying data and metabolite structural analysis, 
workflow. 
The objective of the present study was to apply shotgun fingerprinting to assess 
compliance to almond consumption by screening for prospective biomarkers in 
erythrocytes that were discriminatory between individuals that consumed almonds and 
those that did not consume any nuts. In addition, because almonds also contain 
substantial amounts of flavonoids (Bolling et al. 2011), we screened the literature for 
flavonoids identified in almond skins (Bolling et al. 2009) and included them in the 





were related to lipids and metabolites in erythrocytes, indicated the presence of 19 
molecule ratios highly discriminatory between individuals that consumed almonds and 
those that did not consume any nuts. Out of the 19 ratios, 5 were explored in more detail. 
The 10 m/z values present in the five selected ratios have been further analyzed by full 
MS/MS to obtain some structural identification. The results suggest that long term 
almond consumption impacts erythrocyte cell membrane composition. This information 
can be useful for assessing compliance to long-term almond consumption. Nonetheless, it 
is important to consider that the identified informative ion combinations related to lipids 
are only prospective biomarkers. Detailed structural identification (presence of isobars 
and isomers, location of unsaturation in the fatty acyl residues) and absolute 
quantification by LC-MS/MS and/or high mass resolution will come at later stages. 




Sixty-one healthy male and female overweight or obese individuals (age: 18 60 
and BMI: 25-40 kg/m2) participating in an almond weight loss study (ClinicalTrials.gov 
(registration number: NCT02360787)) were recruited.  
 
6.4.2 Intervention 
The study was a randomized, controlled, parallel-arm, 12-week, clinical trial. 
Participants were randomized into one of two 500 kcal energy-restricted study arms: 





analyses using 24-hour food recalls were conducted to determine the pa 	
compliance to dietary recommendations. Participants randomized into the almond-
enriched energy restricted diet group (n=31) were asked to consume dry-roasted, lightly 
salted almonds providing 15% energy in their individualized energy-restricted diet. 
Participants randomized into the nut-free energy restricted diet group (n=30) were asked 
to avoid all nuts, seeds and nut products during the intervention period. 
 
6.4.3 Sample extraction and shotgun fingerprinting data acquisition 
Fasting blood samples (5 ml) were collected from participants at baseline and the end of 
the 12 week intervention into vacutainers with EDTA. The erythrocytes were separated 
from the plasma by centrifugation and frozen at -80ºC. The erythrocytes were prepared 
by hemolyzing the cells two times in deionized distilled water followed by centrifugation 
at 4000 RPM for 10 minutes at 4ºC (Allegra 25R centrifuge; Beckman Coulter, Brea, 

            
      
The lipid extracts were prepared using a procedure by Rose and Oklander (Rose 
and Oklander 1965). Erythrocytes (150uL) were mixed with 150uL of ultrapure water 
and the contents were allowed to stand for 15 min with occasional mixing (vortex). 
Isopropanol (1.0 mL) was added to the mixture with occasional mixing. After 30 minutes, 
600uL of chloroform was added, mixed and allowed to stand for another 30 minutes. The 
tube was centrifuged at 10,000xg for 10min (Taylor Scientific Centrifuge). The lipid 
extract (bottom phase) was subsequently removed and transferred to another tube and the 
solvents were removed by evaporation in a Speed Vac concentrator. Dried Lipid extracts 





at 3:6.65:0.35 volume ratios. The solvent pumped by the microsampler between 
injections was ACN + 0.1% formic acid. 
The lipid extract from almond seeds was prepared using a procedure by Bligh and 
Dyer (Bligh and Dyer 1959) for comparison purposes. Four almond seeds were 
individually homogenized in 1 mL of water using a Precellys®24 tissue homogeneizer 
(Bertin Technologies, Rockvielle, MD, USA). The homogenate (800 uL) was transferred 
to a 15mL Falcon tube and mixed with 1 mL of chloroform and 1.6 mL of MeOH. After 
mixing and 15 min incubation at room temperature, 1 mL of chloroform and 1 mL of 
water were added, causing the formation of a 2-phase solution. The lipid extract (bottom 
phase) was subsequently removed and dried under N2 stream. Aliquots of the four 
almond seeds were then combined for further experiments. 
Lipid extracts (6 µL) from individual participants and the almond seeds were 
delivered using FIA-MS to a triple quadrupole mass spectrometer (Agilent QQQ 6460) 
equipped with a jet stream ESI ion source. The lipid extracts from participants were 
pooled into 3 groups for running the diverse scan modes and finding the lipids detectable 
in the samples. The first group comprised of lipid extracts of all participants at baseline 
(n=52) regardless of intervention group (Baseline), the second group comprised of lipid 
extracts of participants that consumed almonds at the end of the intervention (W12-
almonds, N=30), and the third group comprised of lipid extracts of participants that did 
not consume any nuts or nut products at the end of the intervention (W12-control; N=31). 
These classifications were made based on the information obtained from the scans run on 





Full scan at the positive and negative ion modes and over 80 scan modes were run 
on the lipid extracts from the 3 pooled samples and almond seeds (data not shown); 
nonetheless, only 20 scans were informative, i.e. presented ions (Table 6-2). Initial data 
processing of the profiles obtained was carried out by MassHunter (B.06.00). The most 
informative ions identified through the scans on the pooled samples and the almond seeds 
were organized into two methods (one for the positive and another one for the negative 
ion mode) for multiple reaction monitoring (MRM) or single ion monitoring (SIM). With 
the inclusion of the m/z values related to anthocyanins, 243 values of m/z were monitored 
in the 114 individual samples of the three experimental groups. It is important to consider 
that some of the m/z values present in the shotgun lipidomics profiles and selected for 
screening may be isotopic patterns and some may have more than one molecule (isobaric 
and isomeric compounds). Therefore, structural identification of the m/z values was not 
pursued until the relevant ones were isolated by univariate and multivariate analysis. 
Also, we included in the MRM and SIM methods ions compatible with flavanoids present 
in almonds and nuts (Bolling et al. 2009; Gu et al. 2003). In total, 243 SIM or MRMs 
related to lipids and flavonoids were monitored in individual samples organized into two 
methods i.e. positive ion mode   148 values of m/z, negative ion mode   106 values of 
m/z. 
 
6.4.4 Data analysis 
For the informative shotgun fingerprinting scans (Table 6-2), the mass spectra had 
the background subtracted and values of m/z were exported for organization into the two 





mzML format using MSConvert (http://proteowizard.sourceforge.net), and an in-house 
script was developed to sum the ion intensities from 0.4-1.0 min of data acquisition of 
each of the 243 m/z values monitored. The values of ion intensities of each m/z were 
normalized by total ion current (TIC) to obtain relative ion intensities. The dataset was 
then filtered out to remove any ions that did not appear in over 50% of the samples. Data 
were then auto scaled. The differences in the erythrocyte metabolome due to the diet 
factors (W12-Almond versus W12-Control) and time of intervention factors (Baseline 
versus W12) were analyzed via univariate (volcano plots) and multivariate (PCA) 
statistics using Metaboanalyst 3.0 (Xia et al. 2015). The performance of the identified 
metabolites in discriminating W12-Almond from W12-Control was evaluated by 
constructing receiver operating characteristic curves (ROCs) on the dataset, and 
estimating the area under the curve (AUC). The 50 most informative values of m/z i.e. 
those discriminating between W12-Almond versus W12-Control with AUC>0.75 were 
considered for computation of different combinations and ratios by hand and using the 
ROC feature of Metaboanalyst. The ratios with AUC>0.89 were considered as 
informative and submitted to PCA to visualize the difference between groups. The 50 
informative values of m/z were also submitted for MS/MS analysis for lipid class and 
unsaturation level attribution (data shown only for the values of m/z present in the 5 
selected ratios; Figure 6-5). 
 
6.5 Results and discussion 
The overall goal of this research was to assess compliance to an almond 





This analytical strategy is shown to be informative, rapid and a high-throughput strategy 
for erythrocyte metabolomic screening. The workflow utilized in the study (Figure 6-1) 
was based on fast sample preparation of erythrocytes, lipid profiling via FIA-MS 
including full scan, screening of flavanoids and multidimensional MS scans targeted at 
specific functional groups of metabolite classes. 
Multivariate analyses of shotgun fingerprinting by principle component analyses 
(PCA) of all 243 ions showed no clear discrimination between the erythrocyte 
metabolome of the two intervention groups at baseline which was expected (Figure 6-
2A). In addition, we did not see a discrimination between the metabolomic profiles of the 
two groups over time (Baseline vs. W12) (Figure 6-2A). This could be a result of an 
absence of a diet standardization phase prior to the start of the intervention. Hence, 
participants may have either been consuming nuts or abstaining from nut consumption 
prior to the intervention and this could have confounded identifying differences over time 
in each group. However, we did see a relatively distinct clustering of the almond and 
control groups at the end of the intervention (Figure 6-2B). This may indicate that either 
some participants were not complaint to their respective intervention groups or that the 
metabolites were not the best biomarkers of almond consumption. 
Nevertheless, we evaluated the performance of the most informative ions 
indicated by ROC analysis (n=50, AUC>0.75) in discriminating between the almond and 
the control groups at the end of the intervention. In addition, we evaluated the 
performance of different combinations and ratios of all metabolites as relationships 
between multiple metabolites can capture information lost in univariate and multivariate 





individual metabolites alone (Steuer 2006). Out of the 243 ions monitored, 9 were 
observed in 19 ratios and/or combinations which presented ROC curves with AUC>0.89. 
A PCA of the 19 ratios demonstrated a distinct clustering with very little overlap of the 
almond and control groups at the end of the intervention (Figure 6-3). Out of the 19 
ratios, 5 ratios that presented the most unique combinations of ions and those with the 
most informative fold changes were selected (Table 6-3). 
Structural information obtained from the MS/MS experiments of the m/z values 
included in the 5 selected ratios is listed in Table 6-4. Most ions presented the fragment 
of m/z 184 which is diagnostic of phosphatidylcholine (PC) and sphingomyelin (SM) 
lipids. Also values of m/z coincident with flavonoids were included in the ratios. 
However, MS/MS was not diagnostic for these ions (Table 6-4). 
All 5 ratios had a sensitivity of 74.2% and specificity of 86.7% (Figure 6-4) i.e. 8 
out of the 31 participants in the almond group and 3 out of the 30 participants in the 
control group were misclassified indicating a possibility of non-compliance. To confirm 
whether these participants were non-compliers in their respective intervention groups, we 
evaluated their dietary intake data. Non-compliers in the almond group demonstrated a 
trend for either reduction in or inconsistent intake of MUFA, arginine, vitamin E and 
phytic acid (nutrients that are high in almonds) over the intervention period while non-
compliers in the control group demonstrated a trend for either an increase in or 
inconsistent intake of the aforementioned nutrients over the intervention period 
(unpublished data). In contrast, participants that were categorized as compliers in the 
almond group had greater MUFA, arginine and vitamin E intake over the intervention 





precluded a statistical determination of the dietary intake data, it is reasonable to assume 
that based on shotgun fingerprinting and dietary intake data, they might not have been 
complaint to their respective intervention groups.  
However, additional studies to are still needed to validate compliance to almond 
consumption in clinical trials using this approach. The concept of shotgun fingerprinting 
is similar to full mass scan profiling/fingerprinting used in a number of studies for food 
quality (Porcari et al. 2016; Saraiva et al. 2009; Sawaya et al. 2010) and proof of origin, 
adulteration (de Souza et al. 2007; Haddad et al. 2008), developmental biology (Ferreira 
et al. 2015), bacterial identification (Barreiro et al. 2012; Song et al. 2007) and disease 
diagnosis (Alfaro et al. 2016; Wiseman et al. 2005). We propose the use of 
multidimensional scans and a much simpler workflow compared to traditional 
metabolomics for biomarker discovery based on liquid (LC) or gas chromatography 
(GC), or capillary electrophoresis (CE). This analytical approach is mainly based on 
shotgun lipidomics features that use relative amounts of data and biomarker-discovery 
based statistic tools. The guiding principle of the method is the high-throughput 
utilization of the unique chemical and physical properties of small molecules present in 
the samples. Shotgun fingerprinting presents limitations for precise structural 
identification of the prospective biomarker combinations proposed due to the lack of 
chromatographic separation combined with frequent isomeric and isobaric nature of 
lipids. Therefore, more than one lipid isomer or even lipid class of compounds may be 
present at the same m/z and the molecular species. Even though we have acquired 
MS/MS data of the most relevant ions described in the study (Figure 6-5), they should be 









The exploration of the erythrocyte metabolome in 61 subjects (W12-Almond and 
W12-Control samples) by shotgun fingerprinting identified ratios and combinations of 
specific ions mainly related to membrane lipids which were discriminatory of almond 
consumption from the nut-free diet at the end of the 12 week intervention. While we 
cannot ascertain at this point whether the informative metabolites detected are biomarkers 
of almond consumption, the relationship between different metabolites indicates almond-
induced changes in the metabolomics profile and the misclassifications observed as a 
result of the ratio performance evaluation could be indications of possible non-
compliance as supported by the dietary intake data. Nevertheless, the repeatability and 
validity of this method will have to be tested in future studies with larger datasets and 
more certain control of dietary compliance. 
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Table 6-1: Baseline characteristics of participants in the intervention 
Characteristic Almond-enriched diet 
(n=31) 
Nut-free diet  
(n=30) 
Sex [n (%)] 
Male 7 (22.6) 6 (20) 
Female 24 (77.4) 24 (80) 
Age (y) 32.06±13.61a) 33.40±13.21 
BMI (kg/m2) 29.97±3.34 30.93±4.52 























Table 6-2: Informative scan modes for screening diverse lipid classes in the shotgun 
lipidomics study 
Scan mode Ion detected Targeted lipids/metabolites 
full scan negative [M-H]- Free fatty acids, cholesterol sulphate 








NL 141 [M+H]+ Phosphatidylethanolamine (PE) 
NL 183 [M+H]+ Phosphatidylcholine (PC), alkelnyl-acyl PC 
(ePC), sphingomyelin (SM) and LysoPC 
PREC 184 [M+H]+ Phosphatidylcholine (PC), alkelnyl-acyl PC 
(ePC), sphingomyelin (SM) and LysoPC 
PREC 255.2 [M-H]- Glycerolipids containing Palmitic acid residue 
PREC 264.3 [M+H]+ Ceramides (d18:1; sphingosines)/cerebrosides 
PREC 266.4 [M+H]+ Ceramides (d18:0; sphinganines) 
PREC 279.2 [M-H]- Glycerolipids containing linolenic acid residue 
PREC 281.2 [M-H]- Glycerolipids containing oleic acid residue 
PREC 282.2 [M+H]+ Ceramides (t18:0 4-hydroxysphinganines) 
PREC 283.2 [M-H]- Glycerolipids containing stearic acid residue 
PREC 303.2 [M-H]- Glycerolipids containing arachidonic acid 
PREC 305.2 [M-H]- Glycerolipids containing eicosatrienoic residue 
PREC 327.3 [M-H]- Glycerolipids containing 
docosahexaenoic (DHA) residue 
PREC 329.3 [M-H]- Glycerolipids containing Eicosapentaenoic 
acid (EPA) residue 
PREC 331.3 [M-H]- Glycerolipids containing 
docosatetraenoic acid residue 
PREC 85 [M+H]+ Acylcarnitines 
PREC 97 [M-H]- Sulfatide (ST) 










Table 6-3: Fold change of the five selected m/z ratios and combinations between almond 
diet group and nut-free diet group at the end of the 12 week intervention i.e. (W12-
almond/W12-control). 
Selected m/z ratiosa) Fold 
change 
log2(FC) P-value 
(447 X 930.5) / (703.5 X 988.5 X 2.5901 1.373 0.000000172 
(447 X 930.5)/ (703.5 X 876.5) 4.7656 2.2527 0.00000546 
(447 X 930.5 X 782.5)/ 703.5 8.5938 3.1033 0.0001237 
(447 X 930.5 X 782.5)/ 813.5 -> 629.5 9.083 3.1832 0.00012746 
(447 X 930.5)/ (703.5 X 814.5) 6.8211 2.77 0.0000514 
a) Ion intensities have been measured by monitoring just the parent ion both in Q1 and 
Q3, except for the m/z 813.5, which has had the fragment of m/z 629.5 monitored. Ion 






Table 6-4: Metabolites associated with almond consumption in the shotgun 
fingerprinting of participants  erythrocytes. 
m/z Ion Attribution (MS/MS) 
447 [M-H] - Not attributeda) 
703.5 [M+H] + Sphingomyelin SM (d18:1/16:0) 
or SM(d16:1/18:0)b) 
930.5 [M]+NH+ TAG(56:3)c) 
782.5 [M+H] + Phosphatidylcholine PC(36:4)b) 
814.5 [M+H] + PC(38:2)b) 
813.5 [M+H] + SM (d18:2/24:0) or SM(d18:1/24:1) 
813.5 -> 629.5 [M+H] + SM (d18:2/24:0) or SM(d18:1/24:1) 
876.5 [M]+NH+ Not attributedd) 
988.5 [M]+NH+ TAG (62:16)c) 
1016.5 [M+H]+ or [M]+NH+ Not attributede) 
a) Value of m/z expected for diverse flavonols (such as Kaempferol 3-O-glucoside and 
Quercetin) but fragments expected were not found by MS/MS. 
b) Attribution was based on presence of the fragment ion at m/z 184 corresponding to 
the glycerolipid polar head (phosphocholine), which is present in the product ion 
analysis of protonated choline-containing phospholipid molecular species such as 
phosphatidylcholine (PC) and sphingomyelin (SM). Metlin database 
(https://metlin.scripps.edu) was used to search attributions. See Figure 6-5 for MS/MS 
spectra. 
c) TAG  triacylglycerol. In parenthesis are the number of carbon in the TAG fatty acyl 
residues and the number of unsaturations, separated by a colon. Tentative attribution 
due to lack of specific fragments for TAG lipids 
d) MS/MS spectrum with no fragments up to collision energy of 35. Values of m/z not 
compatible with TAG. 













Figure 6-1: Shotgun fingerprinting study workflow for almond consumption compliance 
Lipid extracts were injected without chromatographic separation into the ESI source (flow 
injection) and data on full mass scan and on diverse shotgun lipidomics scan modes were 
collected for each representative sample (pooled baseline, pooled W12-almond and pooled 
W12-control samples). The ions observed and m/z values of flavonoids reported in 
literature were organized into two methods including SIM or MRM. Since this workflow 
is mostly based on multidimensional MS experiments to perform chemical profiling, we 












Figure 6-2: PCA score plots of all 243 ions 
(A) PCA score plot of all 243 ions at baseline and W12. Colors indicate the experimental 
groups. Red dots are from the almond group before diet intervention (baseline); green 
dots are from the control group at baseline; dark blue dots are from the almond group 
after the 12 week intervention (W12-Almond); and light blue dots are from the control 
group after the 12 week intervention (W12-Control). (B) PCA score plot of all 243 
values of m/z for the W12-Control and W12-Almond groups. Red dots represent W12-
Almond group; and green dots the W12-Control samples. The circles are drawn for 











Figure 6-3: PCA score plot of the 19 m/z value ratios presenting AUC>0.89 
Colors indicate the experimental groups. Grey dots are from the almond group after the 
12 week intervention (W12-Almond); and black dots are from the control group after the 





























Figure 6-4: Performance analysis of selected m/z ratios using ROC univariate curves 
Graphs for ratios 1 to 5 show the averages, ±SD and error for the values. Individual 
samples of W12-Almond and W12-control are depicted as open and solid symbols, 



























Figure 6-5: MS/MS spectrum of informative m/z values in ratios 
(A) MS/MS spectrum of m/z 447 from almond seed extract; (B) MS/MS spectrum of m/z 
    	
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	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collision energy no fragment characteristic of polar head fragment or neutral were observed. 
Therefore a tentative attribution as a TAG is proposed. (E) MS/MS spectrum of m/z 782.5 
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of polar head fragment or neutral were observed. Therefore a tentative attribution as a TAG 
is proposed. Note: W12-almond and W12-control were pooled for the acquisition of 
MS/MS data from erythr	







CHAPTER 7. SUMMARY AND FUTURE RESEARCH DIRECTIONS 
7.1 Summary 
Nut consumption can aid weight management due to their strong satiating effects, 
the inefficient absorption of their energy, and possibly by elevating energy expenditure 
and fat oxidation (Chapter 2). In addition, nuts have beneficial effects on body 
composition, cardiovascular health, and cognitive function (Chapter 3). The unique 
nutrient profile of nuts can also modulate the post-lunch dip in cognitive function 
(Chapter 3).  
This dissertation focused on almond consumption with three overall primary 
aims. The first was to evaluate the effects of almond consumption as part of an energy-
restricted diet on weight, body composition specifically the visceral depots and blood 
pressure compared to a nut-free energy restricted diet (Chapter 4). The second was to 
evaluate the effects of almond consumption as part of an energy-restricted diet on the 
memory and attention domains of cognitive function (Chapter 5). The third was to 
evaluate the acute effects of almond consumption on the post-lunch dip in the memory 
and attention domains of cognitive function (Chapter 5). This research also contributed to 
the methods literature by developing an analytical approach to identify metabolic profiles 






7.2 Major findings 
 This dissertation provides new evidence for the beneficial effects of almond 
consumption on body composition and blood pressure in the context of energy restriction 
as well as for the acute effects of almond consumption in ameliorating the post-lunch 
decline in cognitive function. The major findings of all the studies are presented below. 
 
7.2.1 The effects of almond consumption on weight-related clinical outcomes  
  Almond consumption during a 12 week weight loss regimen compared to a nut-
free weight loss regimen resulted in: 
o Greater proportional reductions in trunk and total body fat mass in 
participants compliant to the intervention 
o Greater proportional increases in trunk and total body fat-free mass in 
participants compliant to the intervention 
o Greater reductions in diastolic blood pressure in participants compliant to 
the intervention 
o Similar reductions in weight, visceral adipose tissue, anthropometric 
measures of abdominal adiposity such as SAD and waist circumference, 
and systolic blood pressure for all participants 
o Similar reductions in twenty-four hour hunger and desire to eat ratings for 
all participants 
  Both the almond-enriched and nut-free weight loss diets demonstrated no changes 
in the following outcomes over the 12 week weight loss intervention 





o Twenty-four hour ambulatory systolic and diastolic blood pressure  
o Fasting serum lipid profile i.e. HDL, LDL, total cholesterol, and 
triglycerides 
o Fasting serum insulin and glucose. Although there was a significant but 
not clinically relevant increase in fasting glucose levels for all participants, 
fasting glucose concentrations remained unchanged for participants 
compliant to the intervention.   
  Almond palatability and acceptance ratings remained unchanged over the weight 
loss intervention in participants compliant to the intervention. 
  Compliance rates to energy restriction were similar in the almond-enriched and 
nut-free weight loss diets 
  Age, sex and BMI had no effects on the aforementioned outcomes. 
 
7.2.2 The effects of almond consumption on cognitive function and the post-lunch dip 
in cognitive function 
  Both the almond enriched diet and nut-free weight loss diets resulted in similar 
improvements in the memory and attention indices of cognitive function for all 
participants after 12 weeks. 
  In the post-lunch dip analysis, consumption of an almond enriched high fat lunch 
compared to the high carbohydrate lunch resulted in: 
o Amelioration of the post-lunch decline in the memory domain of cognitive 
function 





  Age of participants was negatively correlated with attention performance indices 
of cognitive function 
  Gender, BMI and amount of weight lost had no effect on the cognitive function 
outcomes over the 12 week intervention as well as in the post-lunch dip analysis. 
 
7.2.3 The assessment of almond consumption compliance using an untargeted 
metabolomics approach 
  Specific ratios and combinations of mainly membrane lipids such as 
phosphatidylcholine and sphingomyelin were discriminatory of the almond-
enriched diet from the nut-free diet at the end of the 12 week intervention.  
  The relationship between these metabolites indicates almond-induced changes in 
the metabolomics profile. 
  The misclassifications, 25.8% in the almond group and 10% in the nut-free group 
observed as a result of the ratio performance evaluation could be indications of 
possible non-compliance as supported by dietary intake data. 
 
7.3 Future research directions 
  Would almond consumption elicit greater visceral fat loss in individuals with 
greater obesity? 
o Very few studies have directly assessed the effects of nut consumption on 
visceral fat and have found inconsistent results(1 3). However, none of 
these studies exclusively recruited obese individuals. Although visceral 





with total body fat and hence is expected to be higher in obese individuals 
than overweight individuals. Although this dissertation research showed a 
trend for greater visceral fat loss with almond consumption (Chapter 3), it 
was not powered to detect a difference between overweight and obese 
individuals. Therefore, additional research is needed to establish if almond 
consumption in the context of energy restriction can result in significant 
visceral fat loss in obese individuals. 
 
  Would the effects of almonds on blood pressure be more pronounced in 
individuals at high CVD risk? 
o The participants in this dissertation research were overweight or obese 
with no other CVD risk factors. The majority of research demonstrates no 
effects of nut consumption on blood pressure in individuals without 
elevated CVD risk(5). Despite recruiting only low CVD risk individuals we 
observed a greater reduction in diastolic blood pressure with almond 
consumption compared to the nut-free diet (Chapter 3). However, the 
health impact of almond consumption may be greater among individuals at 
high CVD risk and needs to be investigated further.  
 
  Can almond consumption in long-term clinical trials result in monotony effects?  
o Past research on almond influences on ingestive behavior has largely 
focused on the presumed hormonal regulation (ghrelin, CCK, PYY, etc.) 





hormones, measured in the circulation, for appetite and intake is weak(6). 
This may be due to a dominating effect of the reward system over the 
appetitive system and poor correlation between circulating and brain 
hormone concentrations(7).  Emerging technologies, such as neuroimaging, 
allow for a more direct assessment of brain activity in appetitive and 
reward centers. Data from these studies indicate that increased activity 
elicited by visual food stimuli in the mesolimbic dopamine system and 
related brain structures is associated with increased appetitive drive and 
motivated behavior(8,9). Documentation of almond effects on brain reward 
centers would add considerable strength to the evidence that they are 
palatable yet satiating and resistant to monotony effects, a combination 
ideal for weight management. 
 
  What approaches may be implemented to identify and validate the biomarkers of 
almond consumption? 
o The metabolomics study presented in Chapter 6 raises important questions 
concerning the unattributed metabolites that were discriminatory between 
the almond enriched diet and the nut-free diet at the end of the 
intervention. Those metabolites could be by products of microbial 
degradation of flavonols as described by Urpi-Sarda et al(10). However, 
that study assessed the metabolomic profiles of phenolic metabolites in 
plasma and urine samples after consumption of almond skin polyphenols 





several respects, including study design, biological samples (we used 
erythrocytes), and metabolites screened, it provides some insight into the 
identity of the unattributed metabolites. Nevertheless, there is a need for 
detailed structural identification and absolute quantification by LC-
MS/MS and/or high mass resolution for biomarker validation which can 
be explored in future studies. 
 
  Does almond consumption at lunch ameliorate the post-lunch decline in cognitive 
function by moderating glycemia? 
o This dissertation research showed that almond consumption at lunch 
reduced the post-lunch decline in cognitive function (Chapter 5) but the 
underlying mechanisms are unknown. Lower and higher than normal 
concentrations of plasma glucose are known to impair cognition(11). 
Almonds moderate postprandial blood glucose concentrations(12,13). There 
is also evidence to suggest that low glycemic index meals improve 
cognitive performance compared to higher glycemic index meals(14). 
Hence, consumption of almonds with a meal can reduce the glycemic 
impact of carbohydrate, thereby maintaining optimum blood glucose 
concentrations for effective cognitive performance. However, monitoring 
plasma glucose concentrations during the post-lunch phase when cognitive 
function is waning might prove to be tricky as multiple measurements 
within a short period can interfere with the decline in cognitive function 





the study process prior to testing to avoid the confounding effects of study 
methods on cognition. 
 
  How would almond form influence vascular health and cognitive function? 
o Individuals with vascular disease (VD) may have impaired endothelial 
dependent dilation of blood vessels(15,16). Moreover, increasing evidence 
suggests that vascular disease is associated with cognitive dysfunction(17). 
These dysfunctions may be mediated by structural and functional changes 
in the cerebral blood vessels. Epidemiological and clinical evidence 
suggests that almond consumption may be an effective strategy for 
lowering the incidence of VD and preventing cognitive decline(18). 
Almonds contain a range of nutrients, the bioaccessibility of which are 
dependent on the form of almonds. For example, nutrients in more 
processed forms of almonds such as almond meal and almond butter are 
more accessible for absorption than nutrients in whole almonds(19,20). 
Hence, the increased bioavailability of nutrients from more processed 
almond forms may reduce the risk of vascular disease and cognitive 
impairments further. The role of almond form on vascular indices such as 
endothelial function, vascular compliance and cognitive function has not 








  How would the textural attributes of nuts affect acceptability and cognition? 
o Although nuts have similar nutritional profiles, their textures are vastly 
different, for example almonds are harder and more brittle than walnuts. 
The textural properties of foods such as crispiness, crunchiness etc. can 
influence the acceptability and enjoyment of food(21). The effects of 
different textural profiles of nuts on their acceptability has not been 
evaluated. Moreover, the relationship between mastication sounds and 
cognition has not been explored. Foods such as nuts that are harder to 
chew and those that elicit greater mastication sounds may increase 
alertness and potentially affect cognitive function acutely in comparison to 
foods that do not require considerable oral processing efforts. 
 
  What are the effects of lunch skipping and timing of lunch consumption on the 
post-lunch dip in cognitive function? 
o The post lunch dip analysis described in Chapter 5 did not account for the 
timing of lunch consumption and the effects of lunch skipping on 
cognitive function. Although a few studies have shown that the post-lunch 
dip in cognitive function is not affected by the time at which lunch is 
eaten(22,23) there is very limited evidence to derive firm conclusions. In 
addition, there is inconsistent evidence regarding the effects of lunch 
consumption versus no lunch on the post-lunch decline in cognitive 
function(24). Therefore, there is a need to determine whether the post-lunch 





induced by lunch in the late afternoon and whether lunch skipping elicits a 
post-lunch dip which is either more or less pronounced than that 
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